| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | GTPase activator activity | DOCK3 AGAP5 ARHGAP17 DOCK5 ARHGAP31 ERRFI1 AGAP9 AGAP7P AGAP4 AGAP6 AGAP1 | 1.53e-07 | 279 | 100 | 11 | GO:0005096 |
| GeneOntologyMolecularFunction | RNA polymerase II C-terminal domain binding | 1.95e-05 | 11 | 100 | 3 | GO:0099122 | |
| GeneOntologyMolecularFunction | enzyme activator activity | DOCK3 AGAP5 FRS2 PEX12 ARHGAP17 DOCK5 ARHGAP31 ERRFI1 AGAP9 AGAP7P AGAP4 AGAP6 AGAP1 | 2.38e-05 | 656 | 100 | 13 | GO:0008047 |
| GeneOntologyMolecularFunction | nucleoside-triphosphatase regulator activity | DOCK3 AGAP5 ARHGAP17 DOCK5 ARHGAP31 ERRFI1 AGAP9 AGAP7P AGAP4 AGAP6 AGAP1 | 4.69e-05 | 507 | 100 | 11 | GO:0060589 |
| GeneOntologyMolecularFunction | GTPase regulator activity | DOCK3 AGAP5 ARHGAP17 DOCK5 ARHGAP31 ERRFI1 AGAP9 AGAP7P AGAP4 AGAP6 AGAP1 | 4.69e-05 | 507 | 100 | 11 | GO:0030695 |
| GeneOntologyMolecularFunction | chromatin binding | SOX9 E2F4 CITED1 ZNF692 CIC TRIM66 NCOR1 SATB1 CBX6 BRD4 POLQ CABIN1 MNT | 8.05e-05 | 739 | 100 | 13 | GO:0003682 |
| GeneOntologyMolecularFunction | SH3 domain binding | 8.33e-05 | 143 | 100 | 6 | GO:0017124 | |
| GeneOntologyMolecularFunction | protein domain specific binding | DOCK3 WIPF1 WIPF3 ARHGAP17 E2F4 CITED1 NCOR1 ATXN2 ARHGAP31 ERRFI1 TRAK2 ADGRL2 CABIN1 | 4.20e-04 | 875 | 100 | 13 | GO:0019904 |
| GeneOntologyMolecularFunction | histone H3K9 monomethyltransferase activity | 6.82e-04 | 8 | 100 | 2 | GO:0140948 | |
| GeneOntologyMolecularFunction | RNA polymerase II complex binding | 9.77e-04 | 39 | 100 | 3 | GO:0000993 | |
| GeneOntologyMolecularFunction | histone H3K9me2 methyltransferase activity | 1.09e-03 | 10 | 100 | 2 | GO:0140947 | |
| GeneOntologyMolecularFunction | histone H3 methyltransferase activity | 1.39e-03 | 44 | 100 | 3 | GO:0140938 | |
| GeneOntologyMolecularFunction | RNA polymerase core enzyme binding | 1.48e-03 | 45 | 100 | 3 | GO:0043175 | |
| GeneOntologyMolecularFunction | phospholipid binding | 1.72e-03 | 548 | 100 | 9 | GO:0005543 | |
| GeneOntologyMolecularFunction | profilin binding | 1.87e-03 | 13 | 100 | 2 | GO:0005522 | |
| GeneOntologyMolecularFunction | histone H3K9 methyltransferase activity | 1.87e-03 | 13 | 100 | 2 | GO:0046974 | |
| GeneOntologyMolecularFunction | single-stranded DNA endodeoxyribonuclease activity | 1.87e-03 | 13 | 100 | 2 | GO:0000014 | |
| GeneOntologyMolecularFunction | protein-macromolecule adaptor activity | NACA FRS2 AMBRA1 CITED1 ZC3H18 SRCAP MIDEAS NCOR1 SETD5 BRD4 NFKBIB STON2 FLRT2 EPN1 | 1.89e-03 | 1160 | 100 | 14 | GO:0030674 |
| GeneOntologyBiologicalProcess | positive regulation of cellular component biogenesis | SOX9 MAP1B CARMIL1 AMBRA1 CRACD BRAF UBAP2L MED25 CEP295 FLRT2 ADGRL2 EPN1 PHLDB2 | 4.73e-06 | 582 | 100 | 13 | GO:0044089 |
| GeneOntologyBiologicalProcess | activation of GTPase activity | 1.51e-05 | 109 | 100 | 6 | GO:0090630 | |
| GeneOntologyBiologicalProcess | negative regulation of DNA-templated transcription | SOX9 DEAF1 NACA ETV5 MECOM CITED1 POU6F1 MIDEAS ZNF692 CIC SCAF4 TRIM66 NCOR1 SATB1 SETD5 CBX6 MED25 MNT | 1.23e-04 | 1399 | 100 | 18 | GO:0045892 |
| GeneOntologyBiologicalProcess | negative regulation of barbed-end actin filament capping | 1.39e-04 | 4 | 100 | 2 | GO:2000813 | |
| GeneOntologyBiologicalProcess | negative regulation of RNA biosynthetic process | SOX9 DEAF1 NACA ETV5 MECOM CITED1 POU6F1 MIDEAS ZNF692 CIC SCAF4 TRIM66 NCOR1 SATB1 SETD5 CBX6 MED25 MNT | 1.39e-04 | 1413 | 100 | 18 | GO:1902679 |
| GeneOntologyBiologicalProcess | actin filament organization | WIPF1 CARMIL1 WIPF3 ARHGAP17 ZYX CRACD KANK1 BRAF XIRP2 PHLDB2 | 1.82e-04 | 509 | 100 | 10 | GO:0007015 |
| GeneOntologyBiologicalProcess | regulation of cellular component biogenesis | SOX9 MAP1B CARMIL1 AMBRA1 CRACD KANK1 BRAF SETD5 UBAP2L SEC16A MED25 CEP295 FLRT2 ADGRL2 EPN1 PHLDB2 | 1.85e-04 | 1189 | 100 | 16 | GO:0044087 |
| GeneOntologyBiologicalProcess | positive regulation of GTPase activity | 1.87e-04 | 244 | 100 | 7 | GO:0043547 | |
| GeneOntologyBiologicalProcess | substrate adhesion-dependent cell spreading | 1.90e-04 | 109 | 100 | 5 | GO:0034446 | |
| GeneOntologyBiologicalProcess | maintenance of gastrointestinal epithelium | 2.08e-04 | 24 | 100 | 3 | GO:0030277 | |
| GeneOntologyCellularComponent | chromatin | FAM47A SOX9 DEAF1 ETV5 FAM47C E2F4 POGZ POU6F1 XRCC1 SRCAP CIC MEF2D TRIM66 NCOR1 SATB1 ZFHX4 SETD5 CBX6 BRD4 MNT | 2.32e-05 | 1480 | 101 | 20 | GO:0000785 |
| GeneOntologyCellularComponent | histone deacetylase complex | 5.75e-05 | 85 | 101 | 5 | GO:0000118 | |
| HumanPheno | Short 1st metacarpal | 4.09e-05 | 27 | 38 | 4 | HP:0010034 | |
| HumanPheno | Short proximal phalanx of finger | 8.15e-05 | 32 | 38 | 4 | HP:0010241 | |
| HumanPheno | Aplasia/Hypoplasia of the 1st metacarpal | 1.04e-04 | 34 | 38 | 4 | HP:0010026 | |
| HumanPheno | Abnormality of the philtrum | SOX9 DEAF1 MAP1B PCLO POGZ SRCAP SCAF4 SATB1 BRAF SETD5 UBAP2L BRD4 MED25 CEP295 UNC80 | 1.11e-04 | 726 | 38 | 15 | HP:0000288 |
| HumanPheno | Abnormal upper limb bone morphology | SOX9 COL27A1 LAMA5 MECOM POGZ SRCAP BRAF SETD5 ARHGAP31 BRD4 MED25 PRG4 | 1.28e-04 | 484 | 38 | 12 | HP:0040070 |
| HumanPheno | Abnormal finger phalanx morphology | SOX9 DEAF1 KMT2B NUP88 LAMA5 MECOM POGZ SRCAP SETD5 ARHGAP31 UBAP2L BRD4 MED25 PRG4 UNC80 | 1.35e-04 | 738 | 38 | 15 | HP:0005918 |
| HumanPheno | Compulsive behaviors | 1.36e-04 | 158 | 38 | 7 | HP:0000722 | |
| HumanPheno | Short phalanx of the thumb | 1.46e-04 | 37 | 38 | 4 | HP:0009660 | |
| HumanPheno | Aplasia/Hypoplasia of the proximal phalanges of the hand | 1.80e-04 | 39 | 38 | 4 | HP:0009851 | |
| HumanPheno | Abnormal 1st metacarpal morphology | 1.99e-04 | 40 | 38 | 4 | HP:0010009 | |
| HumanPheno | Abnormal finger morphology | DOCK3 SOX9 DEAF1 KMT2B MAP1B COL27A1 NUP88 LAMA5 MECOM MUC5B POGZ SRCAP CIC BRAF SETD5 ARHGAP31 UBAP2L BRD4 MED25 PRG4 UNC80 | 2.27e-04 | 1385 | 38 | 21 | HP:0001167 |
| HumanPheno | Abnormal morphology of bones of the upper limbs | SOX9 LAMA5 MECOM POGZ SRCAP BRAF SETD5 ARHGAP31 BRD4 MED25 PRG4 | 2.28e-04 | 436 | 38 | 11 | HP:0040065 |
| HumanPheno | Restricted or repetitive behaviors or interests | 2.59e-04 | 368 | 38 | 10 | HP:0031432 | |
| HumanPheno | High palate | DOCK3 SOX9 DEAF1 KMT2B MAP1B PCLO NUP88 PEX12 POGZ SCAF4 BRAF UBAP2L BRD4 MED25 CEP295 | 3.10e-04 | 794 | 38 | 15 | HP:0000218 |
| HumanPheno | Short phalanx of finger | 3.13e-04 | 306 | 38 | 9 | HP:0009803 | |
| HumanPheno | Perseverative thought | 3.15e-04 | 377 | 38 | 10 | HP:0030223 | |
| HumanPheno | Aplasia/Hypoplasia of the phalanges of the thumb | 3.43e-04 | 46 | 38 | 4 | HP:0009658 | |
| HumanPheno | Disordered formal thought process | 3.82e-04 | 386 | 38 | 10 | HP:0025769 | |
| HumanPheno | Aplasia/Hypoplasia of the phalanges of the hand | 4.27e-04 | 319 | 38 | 9 | HP:0009767 | |
| HumanPheno | Posteriorly rotated ears | KMT2B MAP1B NUP88 PEX12 POGZ SRCAP SATB1 BRAF UBAP2L BRD4 UNC80 | 4.40e-04 | 470 | 38 | 11 | HP:0000358 |
| HumanPheno | Brachycephaly | 4.42e-04 | 253 | 38 | 8 | HP:0000248 | |
| HumanPheno | Abnormal external nose morphology | DOCK3 SOX9 DEAF1 KMT2B COL27A1 PEX12 POGZ SRCAP SCAF4 BRAF SETD5 UBAP2L BRD4 MED25 CEP295 UNC80 | 4.43e-04 | 916 | 38 | 16 | HP:0010938 |
| MousePheno | fused cornea and lens | 6.89e-09 | 24 | 89 | 6 | MP:0001307 | |
| MousePheno | abnormal viscerocranium morphology | SOX9 AGAP5 COL27A1 LAMA5 MECOM E2F4 ZFHX4 BRAF SETD5 BRD4 ERRFI1 AGAP9 AGAP7P AGAP4 AGAP6 MNT AGAP1 | 1.63e-07 | 593 | 89 | 17 | MP:0005274 |
| MousePheno | abnormal pinna reflex | 2.45e-07 | 101 | 89 | 8 | MP:0001485 | |
| MousePheno | abnormal jaw morphology | SOX9 AGAP5 COL27A1 LAMA5 MECOM ZFHX4 SETD5 BRD4 ERRFI1 AGAP9 AGAP7P AGAP4 AGAP6 MNT AGAP1 | 1.13e-06 | 530 | 89 | 15 | MP:0000454 |
| MousePheno | absent pinna reflex | 1.51e-06 | 89 | 89 | 7 | MP:0006358 | |
| MousePheno | abnormal cranium morphology | SOX9 AGAP5 COL27A1 LAMA5 AMBRA1 MECOM E2F4 ZFHX4 BRAF SETD5 BRD4 ERRFI1 AGAP9 AGAP7P AGAP4 AGAP6 MNT AGAP1 | 2.91e-06 | 813 | 89 | 18 | MP:0000438 |
| MousePheno | abnormal craniofacial bone morphology | SOX9 AGAP5 COL27A1 LAMA5 AMBRA1 MECOM E2F4 ZFHX4 BRAF SETD5 BRD4 ERRFI1 AGAP9 AGAP7P AGAP4 AGAP6 MNT AGAP1 | 3.70e-06 | 827 | 89 | 18 | MP:0002116 |
| MousePheno | abnormal lens development | 9.99e-06 | 78 | 89 | 6 | MP:0005545 | |
| MousePheno | increased circulating potassium level | 1.17e-05 | 121 | 89 | 7 | MP:0005627 | |
| MousePheno | abnormal head morphology | SOX9 AGAP5 KMT2B COL27A1 FRS2 LAMA5 ETV5 AMBRA1 MECOM E2F4 ZFHX4 BRAF SETD5 BRD4 AGAP9 AGAP7P AGAP4 AGAP6 MNT AGAP1 | 1.90e-05 | 1120 | 89 | 20 | MP:0000432 |
| MousePheno | abnormal snout morphology | 3.68e-05 | 257 | 89 | 9 | MP:0000443 | |
| MousePheno | abnormal facial morphology | SOX9 AGAP5 COL27A1 LAMA5 ETV5 AMBRA1 MECOM E2F4 ZFHX4 SETD5 BRD4 AGAP9 AGAP7P AGAP4 AGAP6 MNT AGAP1 | 5.16e-05 | 910 | 89 | 17 | MP:0003743 |
| MousePheno | abnormal ear physiology | AGAP5 SOBP FRS2 MECOM E2F4 MUC5B SATB1 SETD5 MED25 AGAP9 AGAP7P AGAP4 AGAP6 AGAP1 | 9.98e-05 | 684 | 89 | 14 | MP:0003878 |
| MousePheno | abnormal circulating potassium level | 1.08e-04 | 171 | 89 | 7 | MP:0002668 | |
| MousePheno | abnormal skin coloration | 1.58e-04 | 182 | 89 | 7 | MP:0011239 | |
| MousePheno | abnormal fetal growth/weight/body size | 1.63e-04 | 312 | 89 | 9 | MP:0004197 | |
| MousePheno | hearing/vestibular/ear phenotype | SOX9 AGAP5 SOBP FRS2 LAMA5 MECOM E2F4 MUC5B SATB1 SETD5 MED25 AGAP9 AGAP7P AGAP4 AGAP6 AGAP1 | 1.68e-04 | 905 | 89 | 16 | MP:0005377 |
| MousePheno | abnormal tooth morphology | 1.88e-04 | 318 | 89 | 9 | MP:0002100 | |
| MousePheno | abnormal dental arch morphology | 1.92e-04 | 319 | 89 | 9 | MP:0030254 | |
| MousePheno | abnormal fluid regulation | KMT2B MAP1B RAPH1 TRPC1 COL27A1 NACA MECOM E2F4 MUC5B NCOR1 BRAF SETD5 ARHGAP31 FLRT2 PRG4 | 2.07e-04 | 826 | 89 | 15 | MP:0001784 |
| MousePheno | lung epithelium hyperplasia | 2.39e-04 | 4 | 89 | 2 | MP:0010945 | |
| MousePheno | abnormal potassium level | 2.50e-04 | 196 | 89 | 7 | MP:0020887 | |
| MousePheno | abnormal potassium ion homeostasis | 2.66e-04 | 198 | 89 | 7 | MP:0011978 | |
| MousePheno | abnormal mouth morphology | SOX9 AGAP5 COL27A1 LAMA5 MECOM ZFHX4 SETD5 AGAP9 AGAP7P AGAP4 AGAP6 MNT AGAP1 | 3.05e-04 | 670 | 89 | 13 | MP:0000452 |
| MousePheno | abnormal craniofacial morphology | SOX9 AGAP5 COL27A1 FRS2 LAMA5 ETV5 AMBRA1 MECOM E2F4 ZFHX4 BRAF SETD5 BRD4 ERRFI1 AGAP9 AGAP7P AGAP4 AGAP6 MNT AGAP1 | 3.19e-04 | 1372 | 89 | 20 | MP:0000428 |
| MousePheno | craniofacial phenotype | SOX9 AGAP5 COL27A1 FRS2 LAMA5 ETV5 AMBRA1 MECOM E2F4 ZFHX4 BRAF SETD5 BRD4 ERRFI1 AGAP9 AGAP7P AGAP4 AGAP6 MNT AGAP1 | 3.19e-04 | 1372 | 89 | 20 | MP:0005382 |
| MousePheno | abnormal prenatal growth/weight/body size | KMT2B COL27A1 NACA FRS2 LAMA5 MECOM E2F4 CITED1 POGZ XRCC1 MIDEAS NCOR1 RBM12 BRAF SETD5 ARHGAP31 UBAP2L BRD4 RPRD2 CEP295 MNT | 3.56e-04 | 1493 | 89 | 21 | MP:0004196 |
| MousePheno | effusion | 4.14e-04 | 152 | 89 | 6 | MP:0021205 | |
| MousePheno | lethality throughout fetal growth and development | LAMA5 ETV5 AMBRA1 MECOM POGZ MIDEAS NCOR1 SETD5 FLRT2 ADGRL2 | 4.34e-04 | 435 | 89 | 10 | MP:0006208 |
| MousePheno | cornea opacity | 5.26e-04 | 159 | 89 | 6 | MP:0001314 | |
| MousePheno | abnormal pericardium morphology | 5.74e-04 | 225 | 89 | 7 | MP:0000288 | |
| MousePheno | abnormal small intestine goblet cell morphology | 5.91e-04 | 6 | 89 | 2 | MP:0013792 | |
| MousePheno | decreased fetal size | 6.37e-04 | 229 | 89 | 7 | MP:0004200 | |
| MousePheno | abnormal skin morphology | AGAP5 NHSL2 LAMA5 MECOM E2F4 MUC5B NCOR1 CD5 BRAF XIRP2 BRD4 ERRFI1 TRAK2 AGAP9 AGAP7P PRG4 AGAP4 AGAP6 AGAP1 GAREM1 | 6.83e-04 | 1455 | 89 | 20 | MP:0002060 |
| MousePheno | abnormal hearing physiology | AGAP5 SOBP FRS2 MECOM SATB1 SETD5 MED25 AGAP9 AGAP7P AGAP4 AGAP6 AGAP1 | 7.48e-04 | 643 | 89 | 12 | MP:0001963 |
| MousePheno | abnormal fetal size | 7.80e-04 | 237 | 89 | 7 | MP:0004198 | |
| MousePheno | abnormal thymus size | WIPF1 LAMA5 E2F4 SCEL NCOR1 SATB1 BRAF SETD5 ERRFI1 CIZ1 CABIN1 | 8.81e-04 | 564 | 89 | 11 | MP:0002364 |
| MousePheno | abnormal mandible morphology | 8.96e-04 | 176 | 89 | 6 | MP:0000458 | |
| Domain | ArfGap | 7.24e-09 | 29 | 97 | 6 | SM00105 | |
| Domain | ArfGap | 7.24e-09 | 29 | 97 | 6 | PF01412 | |
| Domain | ARFGAP | 7.24e-09 | 29 | 97 | 6 | PS50115 | |
| Domain | ArfGAP | 7.24e-09 | 29 | 97 | 6 | IPR001164 | |
| Domain | Ankyrin_rpt-contain_dom | 6.96e-06 | 254 | 97 | 9 | IPR020683 | |
| Domain | ANK_REP_REGION | 6.96e-06 | 254 | 97 | 9 | PS50297 | |
| Domain | Ankyrin_rpt | 8.94e-06 | 262 | 97 | 9 | IPR002110 | |
| Domain | PH | 1.44e-05 | 278 | 97 | 9 | SM00233 | |
| Domain | PH_DOMAIN | 1.48e-05 | 279 | 97 | 9 | PS50003 | |
| Domain | PH_domain | 1.52e-05 | 280 | 97 | 9 | IPR001849 | |
| Domain | - | 4.51e-05 | 248 | 97 | 8 | 1.25.40.20 | |
| Domain | ANK | 4.91e-05 | 251 | 97 | 8 | SM00248 | |
| Domain | ANK_REPEAT | 5.19e-05 | 253 | 97 | 8 | PS50088 | |
| Domain | PH_dom-like | AGAP5 RAPH1 FRS2 AGAP9 AGAP7P PLEKHA7 AGAP4 AGAP6 PHLDB2 AGAP1 | 7.36e-05 | 426 | 97 | 10 | IPR011993 |
| Domain | FAM47 | 1.59e-04 | 4 | 97 | 2 | PF14642 | |
| Domain | FAM47 | 1.59e-04 | 4 | 97 | 2 | IPR032743 | |
| Domain | - | 1.99e-04 | 391 | 97 | 9 | 2.30.29.30 | |
| Domain | DOCK_N | 2.64e-04 | 5 | 97 | 2 | PF16172 | |
| Domain | DOCK_N | 2.64e-04 | 5 | 97 | 2 | IPR032376 | |
| Domain | - | 3.24e-04 | 26 | 97 | 3 | 1.25.40.90 | |
| Domain | WxxW_domain | 3.95e-04 | 6 | 97 | 2 | IPR025155 | |
| Domain | Mucin2_WxxW | 3.95e-04 | 6 | 97 | 2 | PF13330 | |
| Domain | ENTH_VHS | 4.50e-04 | 29 | 97 | 3 | IPR008942 | |
| Domain | RNA_pol_II-bd | 5.51e-04 | 7 | 97 | 2 | IPR006903 | |
| Domain | CTD_bind | 5.51e-04 | 7 | 97 | 2 | PF04818 | |
| Domain | RPR | 7.32e-04 | 8 | 97 | 2 | SM00582 | |
| Domain | CID | 7.32e-04 | 8 | 97 | 2 | PS51391 | |
| Domain | CID_dom | 7.32e-04 | 8 | 97 | 2 | IPR006569 | |
| Domain | Ank_2 | 8.98e-04 | 215 | 97 | 6 | PF12796 | |
| Domain | PH | 1.24e-03 | 229 | 97 | 6 | PF00169 | |
| Domain | DOCK_C | 1.42e-03 | 11 | 97 | 2 | IPR010703 | |
| Domain | DHR-1_domain | 1.42e-03 | 11 | 97 | 2 | IPR027007 | |
| Domain | DHR_2 | 1.42e-03 | 11 | 97 | 2 | PS51651 | |
| Domain | DHR_1 | 1.42e-03 | 11 | 97 | 2 | PS51650 | |
| Domain | DOCK-C2 | 1.42e-03 | 11 | 97 | 2 | PF14429 | |
| Domain | DHR-2 | 1.42e-03 | 11 | 97 | 2 | IPR027357 | |
| Domain | DHR-2 | 1.42e-03 | 11 | 97 | 2 | PF06920 | |
| Domain | DOCK | 1.42e-03 | 11 | 97 | 2 | IPR026791 | |
| Domain | TIL | 1.70e-03 | 12 | 97 | 2 | PF01826 | |
| Domain | C8 | 1.70e-03 | 12 | 97 | 2 | PF08742 | |
| Domain | Homeodomain-like | 1.72e-03 | 332 | 97 | 7 | IPR009057 | |
| Domain | Unchr_dom_Cys-rich | 2.01e-03 | 13 | 97 | 2 | IPR014853 | |
| Domain | C8 | 2.01e-03 | 13 | 97 | 2 | SM00832 | |
| Domain | TIL_dom | 2.33e-03 | 14 | 97 | 2 | IPR002919 | |
| Domain | WH2 | 2.33e-03 | 14 | 97 | 2 | SM00246 | |
| Domain | VWD | 3.06e-03 | 16 | 97 | 2 | SM00216 | |
| Domain | VWF_type-D | 3.06e-03 | 16 | 97 | 2 | IPR001846 | |
| Domain | VWFD | 3.06e-03 | 16 | 97 | 2 | PS51233 | |
| Domain | WH2 | 3.06e-03 | 16 | 97 | 2 | PF02205 | |
| Domain | VWD | 3.06e-03 | 16 | 97 | 2 | PF00094 | |
| Domain | - | 3.59e-03 | 283 | 97 | 6 | 1.10.10.60 | |
| Domain | CTCK_1 | 3.87e-03 | 18 | 97 | 2 | PS01185 | |
| Domain | VWC_out | 4.31e-03 | 19 | 97 | 2 | SM00215 | |
| Pubmed | SOX9 DEAF1 KMT2B SOBP NACA NUP88 ETV5 MECOM ZC3H18 POGZ XRCC1 SRCAP MIDEAS CIC MEF2D SCAF4 NCOR1 RBM12 SATB1 ZFHX4 ATXN2 UBAP2L NFKBIB SEC16A RPRD2 QSER1 CABIN1 MNT | 4.52e-16 | 1429 | 101 | 28 | 35140242 | |
| Pubmed | GGAPs, a new family of bifunctional GTP-binding and GTPase-activating proteins. | 4.30e-14 | 9 | 101 | 6 | 12640130 | |
| Pubmed | AGAP1/AP-3-dependent endocytic recycling of M5 muscarinic receptors promotes dopamine release. | 1.07e-13 | 10 | 101 | 6 | 20664521 | |
| Pubmed | AGAP1, a novel binding partner of nitric oxide-sensitive guanylyl cyclase. | 2.36e-13 | 11 | 101 | 6 | 15381706 | |
| Pubmed | 8.71e-13 | 13 | 101 | 6 | 27713690 | ||
| Pubmed | 1.52e-12 | 14 | 101 | 6 | 22453919 | ||
| Pubmed | The Nse5/6-like SIMC1-SLF2 complex localizes SMC5/6 to viral replication centers. | DEAF1 MAP1B ZNF207 ZC3H18 POGZ XRCC1 MIDEAS CIC MEF2D SCAF4 NCOR1 ATXN2 PRPF3 UBAP2L BRD4 SEC16A CIZ1 RPRD2 QSER1 PC | 3.93e-12 | 954 | 101 | 20 | 36373674 |
| Pubmed | KMT2B MAP1B RAPH1 POGZ SRCAP MIDEAS ZYX SCAF4 NCOR1 UBAP2L BRD4 SEC16A CIZ1 RPRD2 QSER1 PC | 5.57e-12 | 549 | 101 | 16 | 38280479 | |
| Pubmed | Large-scale characterization of HeLa cell nuclear phosphoproteins. | DEAF1 KMT2B RAPH1 CARMIL1 ZC3H18 POGZ ZYX CIC MEF2D SCAF4 SMTN NCOR1 BRAF UBAP2L BRD4 SEC16A PRG4 PHLDB2 | 9.81e-12 | 774 | 101 | 18 | 15302935 |
| Pubmed | H4K20me0 recognition by BRCA1-BARD1 directs homologous recombination to sister chromatids. | DEAF1 KMT2B NUP88 MECOM ZC3H18 POGZ XRCC1 SRCAP MIDEAS CIC SCAF4 DOCK5 NCOR1 PRPF3 BRD4 CIZ1 RPRD2 QSER1 CABIN1 PC MNT | 1.24e-10 | 1294 | 101 | 21 | 30804502 |
| Pubmed | N-Terminal Acetyltransferase Naa40p Whereabouts Put into N-Terminal Proteoform Perspective. | MAP1B RAPH1 CARMIL1 NACA NUP88 SRCAP ZYX CIC SCAF4 CRACD RBM12 PRPF3 UBAP2L SEC16A CIZ1 RPRD2 PC PKN3 | 2.07e-10 | 934 | 101 | 18 | 33916271 |
| Pubmed | DEAF1 KMT2B WIPF1 ETV5 ZNF207 POGZ XRCC1 MIDEAS ZYX CIC MEF2D SCAF4 NCOR1 RBM12 ATXN2 PRPF3 BRD4 QSER1 MNT | 4.00e-10 | 1103 | 101 | 19 | 34189442 | |
| Pubmed | AGAP5 NACA LAMA5 AMBRA1 POGZ RBM12 ARHGAP31 RPRD2 AGAP9 AGAP7P ADGRL2 AGAP4 AGAP6 AGAP1 | 4.58e-10 | 529 | 101 | 14 | 14621295 | |
| Pubmed | Proteins recruited by SH3 domains of Ruk/CIN85 adaptor identified by LC-MS/MS. | 1.06e-09 | 108 | 101 | 8 | 19531213 | |
| Pubmed | SOX9 DEAF1 ETV5 ZNF207 CITED1 POGZ POU6F1 ZNF692 ZYX CIC MEF2D SATB1 ZNF358 BRD4 MNT | 2.22e-09 | 709 | 101 | 15 | 22988430 | |
| Pubmed | The in vivo Interaction Landscape of Histones H3.1 and H3.3. | SOX9 DEAF1 KMT2B ZC3H18 POGZ XRCC1 SRCAP MIDEAS CIC SATB1 BRD4 CIZ1 QSER1 CABIN1 | 2.73e-09 | 608 | 101 | 14 | 36089195 |
| Pubmed | KMT2B RAPH1 NUP88 MECOM POGZ CIC NCOR1 SATB1 ZFHX4 BRD4 SEC16A PC | 3.53e-09 | 418 | 101 | 12 | 34709266 | |
| Pubmed | Targeting TRIM37-driven centrosome dysfunction in 17q23-amplified breast cancer. | 3.67e-09 | 184 | 101 | 9 | 32908313 | |
| Pubmed | Interaction network of human early embryonic transcription factors. | KMT2B SOBP NUP88 MECOM POGZ MIDEAS NCOR1 SATB1 ZFHX4 SEC16A QSER1 | 6.69e-09 | 351 | 101 | 11 | 38297188 |
| Pubmed | Identification of proximal SUMO-dependent interactors using SUMO-ID. | MAP1B ZNF207 ZYX MEF2D SMTN NCOR1 RBM12 SATB1 PRPF3 UBAP2L SEC16A PC | 6.92e-09 | 444 | 101 | 12 | 34795231 |
| Pubmed | DEAF1 ETV5 ZNF207 E2F4 CITED1 POGZ SRCAP ZYX CIC MEF2D NCOR1 SATB1 BRD4 CIZ1 MNT | 1.27e-08 | 808 | 101 | 15 | 20412781 | |
| Pubmed | AMBRA1 MECOM ZC3H18 POGZ SCEL SRCAP TRIM66 ZFHX4 SETD5 PRPF3 BRD4 SEC16A CIZ1 CEP295 ADGRL2 UNC80 PHLDB2 | 2.28e-08 | 1116 | 101 | 17 | 31753913 | |
| Pubmed | 2.38e-08 | 104 | 101 | 7 | 9205841 | ||
| Pubmed | 5.08e-08 | 116 | 101 | 7 | 30652415 | ||
| Pubmed | Proteome-scale mapping of binding sites in the unstructured regions of the human proteome. | DOCK3 CIC DOCK5 NCOR1 XIRP2 ATXN2 ARHGAP31 STON2 EPN1 PLEKHA7 GAREM1 | 5.33e-08 | 430 | 101 | 11 | 35044719 |
| Pubmed | 9.43e-08 | 268 | 101 | 9 | 33640491 | ||
| Pubmed | A dual-activity topoisomerase complex regulates mRNA translation and turnover. | DOCK3 KMT2B LAMA5 AMBRA1 ARHGAP17 SRCAP TNFRSF21 CIC NCOR1 SETD5 BRD4 SEC16A CABIN1 PC PKN3 GAREM1 | 1.23e-07 | 1105 | 101 | 16 | 35748872 |
| Pubmed | WIPF1 ARHGAP17 POGZ MIDEAS ZYX CIC MEF2D BRAF ARHGAP31 ERRFI1 GAREM1 | 1.82e-07 | 486 | 101 | 11 | 20936779 | |
| Pubmed | Proteomic analyses reveal distinct chromatin-associated and soluble transcription factor complexes. | MAP1B MECOM POGZ XRCC1 CIC MEF2D CRACD NCOR1 SATB1 ZFHX4 QSER1 ADGRL2 CABIN1 MNT | 1.93e-07 | 857 | 101 | 14 | 25609649 |
| Pubmed | An organelle-specific protein landscape identifies novel diseases and molecular mechanisms. | CARMIL1 NUP88 AMBRA1 ZNF207 PCARE E2F4 ZYX DOCK5 SETD5 PRPF3 SEC16A CIZ1 QSER1 PLEKHA7 PKN3 PHLDB2 AGAP1 | 2.52e-07 | 1321 | 101 | 17 | 27173435 |
| Pubmed | 2.68e-07 | 399 | 101 | 10 | 35987950 | ||
| Pubmed | KMT2B RAPH1 WIPF3 SRCAP ZYX CIC SCAF4 CRACD PRPF3 BRD4 RPRD2 | 2.71e-07 | 506 | 101 | 11 | 30890647 | |
| Pubmed | WW domains provide a platform for the assembly of multiprotein networks. | 3.53e-07 | 154 | 101 | 7 | 16055720 | |
| Pubmed | Comparative Application of BioID and TurboID for Protein-Proximity Biotinylation. | NUP88 ZNF207 MIDEAS CIC MEF2D NCOR1 RBM12 ATXN2 SEC16A QSER1 | 9.21e-07 | 457 | 101 | 10 | 32344865 |
| Pubmed | 1.23e-06 | 472 | 101 | 10 | 38943005 | ||
| Pubmed | A central chaperone-like role for 14-3-3 proteins in human cells. | MAP1B RAPH1 CARMIL1 ARHGAP17 ZYX CIC MEF2D BRAF BRD4 SEC16A PC PLEKHA7 PHLDB2 | 1.32e-06 | 861 | 101 | 13 | 36931259 |
| Pubmed | WDR76 Co-Localizes with Heterochromatin Related Proteins and Rapidly Responds to DNA Damage. | 2.34e-06 | 394 | 101 | 9 | 27248496 | |
| Pubmed | Identification and functional characterization of transcriptional activators in human cells. | 2.54e-06 | 398 | 101 | 9 | 35016035 | |
| Pubmed | DOCK3 RAPH1 NACA ARHGAP17 ZNF207 ZYX DOCK5 PRPF3 ARHGAP31 UBAP2L SEC16A PLEKHA7 PKN3 | 2.60e-06 | 916 | 101 | 13 | 32203420 | |
| Pubmed | The TRIM9/TRIM67 neuronal interactome reveals novel activators of morphogenesis. | 3.60e-06 | 218 | 101 | 7 | 33378226 | |
| Pubmed | Characterization of an exchangeable gene trap using pU-17 carrying a stop codon-beta geo cassette. | AGAP5 XRCC1 SCAF4 NCOR1 KANK1 AGAP9 AGAP7P AGAP4 AGAP6 AGAP1 | 3.81e-06 | 536 | 101 | 10 | 15840001 |
| Pubmed | AGAP5 XRCC1 SCAF4 NCOR1 KANK1 AGAP9 AGAP7P AGAP4 AGAP6 AGAP1 | 3.94e-06 | 538 | 101 | 10 | 10512203 | |
| Pubmed | A direct physical interaction between Nanog and Sox2 regulates embryonic stem cell self-renewal. | 4.51e-06 | 146 | 101 | 6 | 23892456 | |
| Pubmed | 4.53e-06 | 83 | 101 | 5 | 28794006 | ||
| Pubmed | The new collagen gene COL27A1 contains SOX9-responsive enhancer elements. | 8.35e-06 | 2 | 101 | 2 | 15922909 | |
| Pubmed | 8.35e-06 | 2 | 101 | 2 | 27863429 | ||
| Pubmed | [Interleukin-1beta induces MUC2/MUC5B gene expression in human nasal epithelial cells]. | 8.35e-06 | 2 | 101 | 2 | 20873538 | |
| Pubmed | A deep proteomics perspective on CRM1-mediated nuclear export and nucleocytoplasmic partitioning. | RAPH1 POGZ ZYX MEF2D UBAP2L NFKBIB ERRFI1 SEC16A RPRD2 TRAK2 EPN1 AGAP1 GAREM1 | 9.97e-06 | 1038 | 101 | 13 | 26673895 |
| Pubmed | 1.31e-05 | 103 | 101 | 5 | 21706016 | ||
| Pubmed | 1.49e-05 | 496 | 101 | 9 | 31343991 | ||
| Pubmed | 1.66e-05 | 503 | 101 | 9 | 16964243 | ||
| Pubmed | Recruitment of the Mammalian Histone-modifying EMSY Complex to Target Genes Is Regulated by ZNF131. | 1.80e-05 | 110 | 101 | 5 | 26841866 | |
| Pubmed | Synaptic GAP and GEF Complexes Cluster Proteins Essential for GTP Signaling. | 1.88e-05 | 281 | 101 | 7 | 28706196 | |
| Pubmed | 1.90e-05 | 645 | 101 | 10 | 25281560 | ||
| Pubmed | Genome-wide association study of blood pressure and hypertension. | 2.23e-05 | 19 | 101 | 3 | 19430479 | |
| Pubmed | 2.48e-05 | 405 | 101 | 8 | 38187761 | ||
| Pubmed | 2.50e-05 | 3 | 101 | 2 | 15240568 | ||
| Pubmed | Stem cell-like transcriptional reprogramming mediates metastatic resistance to mTOR inhibition. | 2.50e-05 | 3 | 101 | 2 | 27991928 | |
| Pubmed | 2.50e-05 | 3 | 101 | 2 | 19959686 | ||
| Pubmed | 2.50e-05 | 3 | 101 | 2 | 19718741 | ||
| Pubmed | ETV5 regulates ductal morphogenesis with Sox9 and is critical for regeneration from pancreatitis. | 2.50e-05 | 3 | 101 | 2 | 29532564 | |
| Pubmed | 2.50e-05 | 3 | 101 | 2 | 33953176 | ||
| Pubmed | KANK1-NTRK3 fusions define a subset of BRAF mutation negative renal metanephric adenomas. | 2.50e-05 | 3 | 101 | 2 | 33046021 | |
| Pubmed | The WH1 and EVH1 domains of WASP and Ena/VASP family members bind distinct sequence motifs. | 2.50e-05 | 3 | 101 | 2 | 12372256 | |
| Pubmed | 2.50e-05 | 3 | 101 | 2 | 21427722 | ||
| Pubmed | 2.50e-05 | 3 | 101 | 2 | 34857762 | ||
| Pubmed | 2.50e-05 | 3 | 101 | 2 | 27499044 | ||
| Pubmed | KMT2B NACA LAMA5 ZNF207 XRCC1 CIC SCAF4 CRACD ATXN2 SETD5 MED25 CIZ1 EPN1 PLEKHA7 AGAP1 | 2.75e-05 | 1497 | 101 | 15 | 31527615 | |
| Pubmed | KSHV episome tethering sites on host chromosomes and regulation of latency-lytic switch by CHD4. | 4.01e-05 | 130 | 101 | 5 | 35545047 | |
| Pubmed | The Functional Proximal Proteome of Oncogenic Ras Includes mTORC2. | 4.33e-05 | 569 | 101 | 9 | 30639242 | |
| Pubmed | 4.99e-05 | 4 | 101 | 2 | 25638393 | ||
| Pubmed | Expression of MUC1, MUC2, MUC5AC and MUC5B in mucinous lesions of the breast. | 4.99e-05 | 4 | 101 | 2 | 22269464 | |
| Pubmed | 4.99e-05 | 4 | 101 | 2 | 23807779 | ||
| Pubmed | 4.99e-05 | 4 | 101 | 2 | 18200045 | ||
| Pubmed | Apoptosis of T cells mediated by Ca2+-induced release of the transcription factor MEF2. | 4.99e-05 | 4 | 101 | 2 | 10531067 | |
| Pubmed | 4.99e-05 | 4 | 101 | 2 | 30810242 | ||
| Pubmed | 4.99e-05 | 4 | 101 | 2 | 17471237 | ||
| Pubmed | 4.99e-05 | 4 | 101 | 2 | 14984930 | ||
| Pubmed | Effects of the Helicobacter pylori Virulence Factor CagA and Ammonium Ion on Mucins in AGS Cells. | 4.99e-05 | 4 | 101 | 2 | 29869461 | |
| Pubmed | 4.99e-05 | 4 | 101 | 2 | 21596555 | ||
| Pubmed | 4.99e-05 | 4 | 101 | 2 | 21414300 | ||
| Pubmed | 4.99e-05 | 4 | 101 | 2 | 12676567 | ||
| Pubmed | NACA ARHGAP17 MECOM XRCC1 KANK1 SEC16A RPRD2 CEP295 QSER1 PKN3 | 5.57e-05 | 733 | 101 | 10 | 34672954 | |
| Pubmed | 6.32e-05 | 233 | 101 | 6 | 37704626 | ||
| Pubmed | Mouse screen reveals multiple new genes underlying mouse and human hearing loss. | AGAP5 RAPH1 CARMIL1 ARHGAP17 TRIM66 FRRS1 SETD5 CBX6 AGAP9 AGAP7P AGAP4 AGAP6 AGAP1 | 6.39e-05 | 1242 | 101 | 13 | 30973865 |
| Pubmed | Menin and Menin-Associated Proteins Coregulate Cancer Energy Metabolism. | 6.40e-05 | 341 | 101 | 7 | 32971831 | |
| Pubmed | Polymorphism of human mucin genes in chest disease: possible significance of MUC2. | 8.30e-05 | 5 | 101 | 2 | 11062147 | |
| Pubmed | Differential expression of MUC genes in endometrial and cervical tissues and tumors. | 8.30e-05 | 5 | 101 | 2 | 16188033 | |
| Pubmed | 8.30e-05 | 5 | 101 | 2 | 27498191 | ||
| Pubmed | 8.30e-05 | 5 | 101 | 2 | 24840470 | ||
| Pubmed | Prdm3 and Prdm16 are H3K9me1 methyltransferases required for mammalian heterochromatin integrity. | 8.30e-05 | 5 | 101 | 2 | 22939622 | |
| Pubmed | 8.30e-05 | 5 | 101 | 2 | 15024082 | ||
| Pubmed | Calmodulin-dependent protein kinase IV regulates nuclear export of Cabin1 during T-cell activation. | 8.30e-05 | 5 | 101 | 2 | 15902271 | |
| Pubmed | CFEOM1-associated kinesin KIF21A is a cortical microtubule growth inhibitor. | 8.30e-05 | 5 | 101 | 2 | 24120883 | |
| Pubmed | 8.30e-05 | 5 | 101 | 2 | 28855737 | ||
| Pubmed | 8.44e-05 | 152 | 101 | 5 | 38360978 | ||
| Pubmed | 8.98e-05 | 360 | 101 | 7 | 33111431 | ||
| Pubmed | 9.02e-05 | 777 | 101 | 10 | 35844135 | ||
| Pubmed | 9.52e-05 | 251 | 101 | 6 | 31076518 | ||
| Pubmed | Fibril treatment changes protein interactions of tau and α-synuclein in human neurons. | 1.05e-04 | 498 | 101 | 8 | 36634849 | |
| Interaction | HNF1B interactions | 4.00e-08 | 190 | 101 | 10 | int:HNF1B | |
| Interaction | SP7 interactions | KMT2B POGZ MIDEAS CIC MEF2D SCAF4 NCOR1 RBM12 SATB1 ZFHX4 RPRD2 QSER1 | 4.03e-08 | 304 | 101 | 12 | int:SP7 |
| Interaction | SMC5 interactions | DEAF1 MAP1B ZNF207 ZC3H18 POGZ XRCC1 MIDEAS CIC MEF2D SCAF4 NCOR1 ATXN2 PRPF3 UBAP2L BRD4 SEC16A CIZ1 RPRD2 QSER1 PC | 9.88e-08 | 1000 | 101 | 20 | int:SMC5 |
| Interaction | NFIX interactions | 2.12e-07 | 227 | 101 | 10 | int:NFIX | |
| Interaction | BAG2 interactions | MAP1B AMBRA1 ARHGAP17 MECOM E2F4 CIC MEF2D DOCK5 TRIM66 NCOR1 BRD4 CIZ1 RPRD2 QSER1 EPN1 | 4.75e-07 | 622 | 101 | 15 | int:BAG2 |
| Interaction | TIMM50 interactions | 7.63e-07 | 261 | 101 | 10 | int:TIMM50 | |
| Interaction | FEV interactions | 8.39e-07 | 203 | 101 | 9 | int:FEV | |
| Interaction | SOX6 interactions | 1.24e-06 | 157 | 101 | 8 | int:SOX6 | |
| Interaction | NAA40 interactions | MAP1B RAPH1 CARMIL1 NACA NUP88 SRCAP ZYX CIC SCAF4 CRACD RBM12 PRPF3 UBAP2L SEC16A CIZ1 RPRD2 PC PKN3 | 1.57e-06 | 978 | 101 | 18 | int:NAA40 |
| Interaction | TBXT interactions | 1.92e-06 | 116 | 101 | 7 | int:TBXT | |
| Interaction | KLF3 interactions | 2.20e-06 | 228 | 101 | 9 | int:KLF3 | |
| Interaction | TLX1 interactions | 2.80e-06 | 175 | 101 | 8 | int:TLX1 | |
| Interaction | CEBPA interactions | DEAF1 KMT2B WIPF1 ETV5 ZNF207 E2F4 POGZ XRCC1 MIDEAS ZYX CIC MEF2D SCAF4 NCOR1 RBM12 ATXN2 PRPF3 BRD4 QSER1 MNT | 3.08e-06 | 1245 | 101 | 20 | int:CEBPA |
| Interaction | PML interactions | KMT2B MAP1B ZNF207 E2F4 XRCC1 ZYX MEF2D SMTN TRIM66 NCOR1 RBM12 SATB1 PRPF3 UBAP2L BRD4 SEC16A PC | 3.65e-06 | 933 | 101 | 17 | int:PML |
| Interaction | PAX9 interactions | 4.11e-06 | 130 | 101 | 7 | int:PAX9 | |
| Interaction | SMG7 interactions | MECOM ZYX MEF2D TRIM66 NCOR1 RBM12 ATXN2 UBAP2L SEC16A RPRD2 | 4.62e-06 | 319 | 101 | 10 | int:SMG7 |
| Interaction | RCOR1 interactions | KMT2B RAPH1 MECOM CIC TRIM66 NCOR1 SATB1 ZFHX4 BRD4 SEC16A PC PKN3 | 6.80e-06 | 494 | 101 | 12 | int:RCOR1 |
| Interaction | PHF21A interactions | 8.72e-06 | 343 | 101 | 10 | int:PHF21A | |
| Interaction | H2BC21 interactions | KMT2B MAP1B PCLO ZC3H18 POGZ XRCC1 SRCAP MIDEAS SCAF4 CBX6 BRD4 MED25 RPRD2 QSER1 | 9.62e-06 | 696 | 101 | 14 | int:H2BC21 |
| Interaction | PAX6 interactions | 1.53e-05 | 366 | 101 | 10 | int:PAX6 | |
| Interaction | FOXK2 interactions | 1.77e-05 | 225 | 101 | 8 | int:FOXK2 | |
| Interaction | PAX8 interactions | 2.02e-05 | 111 | 101 | 6 | int:PAX8 | |
| Interaction | TERF2IP interactions | KMT2B E2F4 ZC3H18 POGZ XRCC1 SRCAP CIC MEF2D NCOR1 BRD4 CIZ1 QSER1 | 2.06e-05 | 552 | 101 | 12 | int:TERF2IP |
| Interaction | TBR1 interactions | 2.24e-05 | 113 | 101 | 6 | int:TBR1 | |
| Interaction | EGR2 interactions | 2.46e-05 | 171 | 101 | 7 | int:EGR2 | |
| Interaction | AKAP8L interactions | 2.81e-05 | 240 | 101 | 8 | int:AKAP8L | |
| Interaction | POLR1G interactions | KMT2B E2F4 ZC3H18 POGZ XRCC1 SRCAP CIC BRD4 NFKBIB CIZ1 RPRD2 | 3.41e-05 | 489 | 101 | 11 | int:POLR1G |
| Interaction | PPIA interactions | MAP1B RAPH1 NACA ZNF207 E2F4 ZC3H18 MIDEAS CIC MEF2D SCAF4 SMTN ERRFI1 SEC16A RPRD2 PKN3 | 3.51e-05 | 888 | 101 | 15 | int:PPIA |
| Interaction | ASF1A interactions | 3.65e-05 | 249 | 101 | 8 | int:ASF1A | |
| Interaction | PAX7 interactions | 3.78e-05 | 124 | 101 | 6 | int:PAX7 | |
| Interaction | ALG13 interactions | 3.80e-05 | 183 | 101 | 7 | int:ALG13 | |
| Interaction | H3C3 interactions | SOX9 KMT2B ZC3H18 POGZ SRCAP MIDEAS CIC SATB1 BRD4 CIZ1 QSER1 | 3.81e-05 | 495 | 101 | 11 | int:H3C3 |
| Interaction | KLF8 interactions | 4.13e-05 | 329 | 101 | 9 | int:KLF8 | |
| Interaction | PRKD2 interactions | 4.20e-05 | 254 | 101 | 8 | int:PRKD2 | |
| Interaction | ACTC1 interactions | KMT2B WIPF1 RAPH1 WIPF3 SRCAP ZYX CIC SCAF4 CRACD PRPF3 BRD4 ERRFI1 RPRD2 | 4.30e-05 | 694 | 101 | 13 | int:ACTC1 |
| Interaction | GATA3 interactions | 4.37e-05 | 187 | 101 | 7 | int:GATA3 | |
| Interaction | LSM14A interactions | 4.95e-05 | 260 | 101 | 8 | int:LSM14A | |
| Interaction | WWTR1 interactions | 5.13e-05 | 422 | 101 | 10 | int:WWTR1 | |
| Interaction | NUP35 interactions | NUP88 ZNF207 MIDEAS CIC MEF2D NCOR1 RBM12 ATXN2 SEC16A QSER1 | 5.34e-05 | 424 | 101 | 10 | int:NUP35 |
| Interaction | SAFB2 interactions | 5.69e-05 | 195 | 101 | 7 | int:SAFB2 | |
| Interaction | HNF4A interactions | 7.33e-05 | 275 | 101 | 8 | int:HNF4A | |
| Interaction | TRPS1 interactions | 8.37e-05 | 143 | 101 | 6 | int:TRPS1 | |
| Interaction | H3-3A interactions | SOX9 DEAF1 KMT2B POGZ XRCC1 SRCAP MIDEAS CIC SATB1 CBX6 BRD4 QSER1 CABIN1 | 9.33e-05 | 749 | 101 | 13 | int:H3-3A |
| Interaction | DUXB interactions | 9.44e-05 | 18 | 101 | 3 | int:DUXB | |
| Interaction | DNAJA3 interactions | 1.02e-04 | 370 | 101 | 9 | int:DNAJA3 | |
| Interaction | HCFC1 interactions | 1.14e-04 | 293 | 101 | 8 | int:HCFC1 | |
| Interaction | SIN3A interactions | 1.24e-04 | 380 | 101 | 9 | int:SIN3A | |
| Interaction | ERG interactions | 1.32e-04 | 223 | 101 | 7 | int:ERG | |
| Interaction | BCOR interactions | 1.40e-04 | 302 | 101 | 8 | int:BCOR | |
| Interaction | TFCP2L1 interactions | 1.41e-04 | 99 | 101 | 5 | int:TFCP2L1 | |
| Interaction | SOX5 interactions | 1.66e-04 | 162 | 101 | 6 | int:SOX5 | |
| Interaction | CBFB interactions | 1.78e-04 | 104 | 101 | 5 | int:CBFB | |
| Interaction | WNK3 interactions | 1.79e-04 | 56 | 101 | 4 | int:WNK3 | |
| Interaction | SH3KBP1 interactions | 1.87e-04 | 315 | 101 | 8 | int:SH3KBP1 | |
| Interaction | CTBP1 interactions | 2.04e-04 | 406 | 101 | 9 | int:CTBP1 | |
| Interaction | HSPB1 interactions | AGAP5 MAP1B AMBRA1 MECOM ZC3H18 ZYX BRAF BRD4 SEC16A AGAP7P PC AGAP4 | 2.20e-04 | 708 | 101 | 12 | int:HSPB1 |
| Interaction | EN1 interactions | 2.31e-04 | 110 | 101 | 5 | int:EN1 | |
| Interaction | DYNLL1 interactions | MAP1B AMBRA1 ZNF207 ZC3H18 POGZ KANK1 CIZ1 PC CCDC136 PHLDB2 | 2.42e-04 | 510 | 101 | 10 | int:DYNLL1 |
| Interaction | SIPA1L1 interactions | 2.44e-04 | 174 | 101 | 6 | int:SIPA1L1 | |
| Interaction | KDM1A interactions | KMT2B RAPH1 NUP88 MECOM E2F4 POGZ CIC MEF2D NCOR1 SATB1 ZFHX4 BRD4 SEC16A PC | 2.48e-04 | 941 | 101 | 14 | int:KDM1A |
| Interaction | TEAD1 interactions | 2.60e-04 | 176 | 101 | 6 | int:TEAD1 | |
| Interaction | HOXA10 interactions | 2.65e-04 | 62 | 101 | 4 | int:HOXA10 | |
| Interaction | FARSA interactions | 2.76e-04 | 178 | 101 | 6 | int:FARSA | |
| Interaction | DOCK3 interactions | 2.82e-04 | 63 | 101 | 4 | int:DOCK3 | |
| Interaction | CREB1 interactions | 2.92e-04 | 254 | 101 | 7 | int:CREB1 | |
| Interaction | LHX2 interactions | 3.21e-04 | 183 | 101 | 6 | int:LHX2 | |
| Interaction | LHX3 interactions | 3.40e-04 | 185 | 101 | 6 | int:LHX3 | |
| Interaction | TOP3B interactions | DOCK3 KMT2B LAMA5 AMBRA1 ARHGAP17 SRCAP TNFRSF21 CIC NCOR1 ATXN2 SETD5 UBAP2L BRD4 SEC16A CABIN1 PC PKN3 GAREM1 | 3.42e-04 | 1470 | 101 | 18 | int:TOP3B |
| Interaction | ELK3 interactions | 3.46e-04 | 120 | 101 | 5 | int:ELK3 | |
| Interaction | SNRNP40 interactions | KMT2B ZNF207 ZC3H18 POGZ XRCC1 MIDEAS SCAF4 NCOR1 PRPF3 BRD4 CIZ1 | 3.49e-04 | 637 | 101 | 11 | int:SNRNP40 |
| Interaction | NCK2 interactions | 3.52e-04 | 262 | 101 | 7 | int:NCK2 | |
| Interaction | EYA2 interactions | 3.59e-04 | 121 | 101 | 5 | int:EYA2 | |
| Interaction | AAK1 interactions | 3.59e-04 | 121 | 101 | 5 | int:AAK1 | |
| Interaction | EHD2 interactions | 4.00e-04 | 69 | 101 | 4 | int:EHD2 | |
| Interaction | HDAC1 interactions | KMT2B RAPH1 NUP88 MECOM E2F4 MIDEAS CIC MEF2D NCOR1 SATB1 ZFHX4 BRD4 CABIN1 PC MNT | 4.02e-04 | 1108 | 101 | 15 | int:HDAC1 |
| Interaction | PRPF40A interactions | 4.06e-04 | 446 | 101 | 9 | int:PRPF40A | |
| Interaction | AR interactions | ETV5 E2F4 SRCAP MIDEAS CIC MEF2D NCOR1 RBM12 PRPF3 UBAP2L BRD4 SEC16A RPRD2 QSER1 | 4.22e-04 | 992 | 101 | 14 | int:AR |
| Interaction | KLF5 interactions | 4.49e-04 | 195 | 101 | 6 | int:KLF5 | |
| Interaction | GATA2 interactions | 5.00e-04 | 199 | 101 | 6 | int:GATA2 | |
| Interaction | NFATC2 interactions | 5.14e-04 | 200 | 101 | 6 | int:NFATC2 | |
| Interaction | FKBP3 interactions | 5.17e-04 | 131 | 101 | 5 | int:FKBP3 | |
| Interaction | DCAF7 interactions | 5.29e-04 | 368 | 101 | 8 | int:DCAF7 | |
| Interaction | GUSBP5 interactions | 5.50e-04 | 75 | 101 | 4 | int:GUSBP5 | |
| Interaction | H3C1 interactions | KMT2B NACA MECOM POGZ XRCC1 SRCAP MIDEAS NCOR1 XIRP2 PRPF3 CBX6 BRD4 CABIN1 | 5.60e-04 | 901 | 101 | 13 | int:H3C1 |
| Interaction | TLE3 interactions | 6.09e-04 | 376 | 101 | 8 | int:TLE3 | |
| Interaction | SEC24C interactions | 6.16e-04 | 207 | 101 | 6 | int:SEC24C | |
| Interaction | RECQL interactions | 6.32e-04 | 289 | 101 | 7 | int:RECQL | |
| Interaction | SSRP1 interactions | MECOM E2F4 ZC3H18 XRCC1 CIC SCAF4 NCOR1 SETD5 PRPF3 BRD4 RPRD2 | 6.40e-04 | 685 | 101 | 11 | int:SSRP1 |
| Interaction | TLX3 interactions | 6.59e-04 | 291 | 101 | 7 | int:TLX3 | |
| Interaction | NFIC interactions | 6.64e-04 | 210 | 101 | 6 | int:NFIC | |
| Interaction | ATXN1 interactions | KMT2B NHSL2 ZNF207 CITED1 ZC3H18 POGZ ZYX CIC DOCK5 NCOR1 ATXN2 UBAP2L BRD4 CCDC136 | 6.68e-04 | 1039 | 101 | 14 | int:ATXN1 |
| Interaction | PPP1CA interactions | DEAF1 NACA MECOM ZC3H18 CIC MEF2D NCOR1 KANK1 BRAF BRD4 RPRD2 | 7.29e-04 | 696 | 101 | 11 | int:PPP1CA |
| Interaction | FOXJ2 interactions | 7.36e-04 | 81 | 101 | 4 | int:FOXJ2 | |
| Interaction | S100A4 interactions | 7.94e-04 | 144 | 101 | 5 | int:S100A4 | |
| Interaction | THOC2 interactions | 8.26e-04 | 219 | 101 | 6 | int:THOC2 | |
| Interaction | RAC1 interactions | DOCK3 RAPH1 CARMIL1 FRS2 ARHGAP17 E2F4 DOCK5 ARHGAP31 STON2 FLRT2 QSER1 ADGRL2 PHLDB2 AGAP1 | 8.34e-04 | 1063 | 101 | 14 | int:RAC1 |
| Interaction | QPRT interactions | 8.43e-04 | 84 | 101 | 4 | int:QPRT | |
| Interaction | CDC42 interactions | WIPF1 RAPH1 CARMIL1 WIPF3 FRS2 ARHGAP17 ZC3H18 ARHGAP31 BRD4 STON2 ERRFI1 FLRT2 QSER1 ADGRL2 PLEKHA7 AGAP1 | 8.68e-04 | 1323 | 101 | 16 | int:CDC42 |
| Cytoband | Ensembl 112 genes in cytogenetic band chr10q11 | 8.16e-04 | 188 | 101 | 4 | chr10q11 | |
| Cytoband | 2q33 | 1.87e-03 | 29 | 101 | 2 | 2q33 | |
| Cytoband | 3q13.33 | 2.00e-03 | 30 | 101 | 2 | 3q13.33 | |
| Cytoband | 1q21.3 | 2.24e-03 | 117 | 101 | 3 | 1q21.3 | |
| Cytoband | 11p15.5 | 2.30e-03 | 118 | 101 | 3 | 11p15.5 | |
| Cytoband | 10q11.23 | 2.42e-03 | 33 | 101 | 2 | 10q11.23 | |
| Cytoband | Xp21.1 | 2.57e-03 | 34 | 101 | 2 | Xp21.1 | |
| GeneFamily | ArfGAPs | 1.18e-09 | 33 | 61 | 6 | 395 | |
| GeneFamily | X-linked mental retardation|Rho GTPase activating proteins|BAR-PH domain containing | 2.22e-09 | 17 | 61 | 5 | 1291 | |
| GeneFamily | Pleckstrin homology domain containing|Rho guanine nucleotide exchange factors|C2 domain containing | 2.82e-08 | 206 | 61 | 9 | 682 | |
| GeneFamily | Ankyrin repeat domain containing | 1.47e-06 | 242 | 61 | 8 | 403 | |
| GeneFamily | LIM domain containing | 1.04e-03 | 59 | 61 | 3 | 1218 | |
| GeneFamily | CD molecules|Mucins | 2.26e-03 | 21 | 61 | 2 | 648 | |
| GeneFamily | Zinc fingers C2H2-type|Lysine methyltransferases|PR/SET domain family | 5.86e-03 | 34 | 61 | 2 | 487 | |
| Coexpression | THEODOROU_MAMMARY_TUMORIGENESIS | 5.94e-09 | 37 | 101 | 6 | MM1121 | |
| Coexpression | GAUSSMANN_MLL_AF4_FUSION_TARGETS_F_DN | 1.77e-08 | 44 | 101 | 6 | MM485 | |
| Coexpression | CHYLA_CBFA2T3_TARGETS_DN | 7.52e-08 | 263 | 101 | 10 | MM1295 | |
| Coexpression | GSE37532_WT_VS_PPARG_KO_LN_TREG_UP | 5.52e-06 | 176 | 101 | 7 | M8952 | |
| Coexpression | GINESTIER_BREAST_CANCER_ZNF217_AMPLIFIED_DN | 6.54e-06 | 338 | 101 | 9 | M17094 | |
| Coexpression | KARLSSON_TGFB1_TARGETS_DN | 1.69e-05 | 209 | 101 | 7 | MM1058 | |
| Coexpression | GOBERT_OLIGODENDROCYTE_DIFFERENTIATION_DN | DEAF1 MAP1B COL27A1 SRCAP TNFRSF21 SCAF4 NCOR1 SSC5D KANK1 RBM12 NFKBIB CEP295 FLRT2 CABIN1 PHLDB2 | 2.07e-05 | 1102 | 101 | 15 | M2369 |
| Coexpression | GOBERT_OLIGODENDROCYTE_DIFFERENTIATION_DN | DEAF1 MAP1B COL27A1 SRCAP TNFRSF21 SCAF4 NCOR1 SSC5D KANK1 RBM12 NFKBIB CEP295 FLRT2 CABIN1 PHLDB2 | 2.61e-05 | 1124 | 101 | 15 | MM1070 |
| Coexpression | LIAO_METASTASIS | 4.55e-05 | 540 | 101 | 10 | M13809 | |
| Coexpression | GSE37301_CD4_TCELL_VS_RAG2_KO_NK_CELL_DN | 7.13e-05 | 180 | 101 | 6 | M8906 | |
| Coexpression | GSE13485_DAY3_VS_DAY21_YF17D_VACCINE_PBMC_UP | 1.05e-04 | 193 | 101 | 6 | M3303 | |
| Coexpression | GSE20152_SPHK1_KO_VS_HTNFA_OVEREXPRESS_ANKLE_UP | 1.17e-04 | 197 | 101 | 6 | M7682 | |
| Coexpression | GSE24671_CTRL_VS_SENDAI_VIRUS_INFECTED_MOUSE_SPLENOCYTES_DN | 1.24e-04 | 199 | 101 | 6 | M9443 | |
| Coexpression | GSE31082_CD4_VS_CD8_SP_THYMOCYTE_DN | 1.24e-04 | 199 | 101 | 6 | M5070 | |
| Coexpression | GSE360_CTRL_VS_L_MAJOR_DC_DN | 1.24e-04 | 199 | 101 | 6 | M5146 | |
| Coexpression | GSE11924_TFH_VS_TH17_CD4_TCELL_UP | 1.24e-04 | 199 | 101 | 6 | M3156 | |
| Coexpression | GSE22601_DOUBLE_NEGATIVE_VS_CD4_SINGLE_POSITIVE_THYMOCYTE_DN | 1.27e-04 | 200 | 101 | 6 | M6243 | |
| Coexpression | GSE10240_CTRL_VS_IL17_STIM_PRIMARY_BRONCHIAL_EPITHELIAL_CELLS_UP | 1.27e-04 | 200 | 101 | 6 | M300 | |
| Coexpression | GSE23505_UNTREATED_VS_4DAY_IL6_IL1_IL23_TREATED_CD4_TCELL_UP | 1.27e-04 | 200 | 101 | 6 | M7856 | |
| Coexpression | THAKAR_PBMC_INACTIVATED_INFLUENZA_AGE_21_30YO_RESPONDERS_7DY_DN | 1.70e-04 | 634 | 101 | 10 | M40866 | |
| Coexpression | THAKAR_PBMC_INACTIVATED_INFLUENZA_AGE_21_30YO_RESPONDERS_28DY_DN | VASH1 E2F4 MIDEAS ZYX MEF2D TRIM66 CBX6 MED25 EPN1 AGAP4 AGAP6 MNT | 1.90e-04 | 905 | 101 | 12 | M40865 |
| ToppCell | droplet-Pancreas-PANCREAS-30m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.54e-08 | 195 | 101 | 8 | 3e519cffa6144a62b06124642a14c9ff39b76554 | |
| ToppCell | (3)_Chondrocytes-(34)_Chondro-progen|World / Cell class and subclass of bone marrow stroma cells in homeostatis | 1.54e-08 | 195 | 101 | 8 | d00cb2fab25f2026a9668a7f0686938a2e7155e2 | |
| ToppCell | droplet-Pancreas-PANCREAS-30m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.54e-08 | 195 | 101 | 8 | 7796ea9247f4c63762f0de8490fed08b9717fa23 | |
| ToppCell | droplet-Trachea-3m-Mesenchymal-fibroblast|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.88e-08 | 200 | 101 | 8 | be527df943a8cedc6452ecef3cafc282db34ceb8 | |
| ToppCell | droplet-Trachea-3m-Mesenchymal-fibroblast-fibroblast_of_trachea-tracheal_fibroblast_l28|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.88e-08 | 200 | 101 | 8 | d254f6634895486f81d7a8b6f006fbc2679eaa5b | |
| ToppCell | droplet-Trachea-3m-Mesenchymal-fibroblast-fibroblast_of_trachea|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.88e-08 | 200 | 101 | 8 | 8e41a484038216f0c2ad258fd46c0e702a4bb8bf | |
| ToppCell | droplet-Trachea-nan-3m-Mesenchymal-fibroblast|Trachea / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.88e-08 | 200 | 101 | 8 | c935caef2988f165e96d8f1ef99ae8963ab9377f | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-kidney_interstitial_fibroblast-kidney_interstitial_fibroblast_5|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.14e-07 | 168 | 101 | 7 | d19a115365c5415e51c039718d7669de788fcf33 | |
| ToppCell | droplet-Lung-30m-Endothelial-arterial_endothelial-pulmonary_artery_endothelial_cell-pulmonary_artery_endothelial_cell_l25|30m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 2.05e-07 | 183 | 101 | 7 | 6f8f997ffc9eaebca2683de125b6069d07c07d26 | |
| ToppCell | pdx|World / Sample and Cell Type and Tumor Cluster (all cells) | 2.28e-07 | 186 | 101 | 7 | de8e538c8767d41b8a52f5e58ba1affd4e7244c4 | |
| ToppCell | pdx-Tumor_cells|World / Sample and Cell Type and Tumor Cluster (all cells) | 2.28e-07 | 186 | 101 | 7 | 0b88a87158a9ca8de3bf40a4ff1687150707a5f0 | |
| ToppCell | Control-Epithelial_cells|Control / group, cell type (main and fine annotations) | 2.46e-07 | 188 | 101 | 7 | 707ebf76cc6fb600b2f07793cf4ea9482c0de79d | |
| ToppCell | Children_(3_yrs)-Epithelial-alveolar_epithelial_cell_type_2-D139|Children_(3_yrs) / Lineage, Cell type, age group and donor | 2.83e-07 | 192 | 101 | 7 | cc9911e182a289779a2612bc213daae5607689e7 | |
| ToppCell | droplet-Trachea-3m-Mesenchymal-myofibroblast-tracheobronchial_smooth_muscle_cell-smooth_muscle_cell_of_trachea_l34|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 3.49e-07 | 198 | 101 | 7 | 3575620db5aeaeb0bdcd7a8ff65c43abd3fa13e4 | |
| ToppCell | droplet-Liver-LIVER_NPC-30m-Endothelial-nan|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.38e-06 | 179 | 101 | 6 | 025d414ec88d5680d99c8173e70ee3bb0b694f74 | |
| ToppCell | 5'-Parenchyma_lung-Endothelial-Lymphatic_EC-endothelial_cell_of_lymphatic_vessel-Lymphatic_EC_differentiating-Lymphatic_EC_differentiating_L.2.5.1.0|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.72e-06 | 182 | 101 | 6 | 53c267ee327e116dbd89d5927ed3bdf78d25ee62 | |
| ToppCell | 5'-Parenchyma_lung-Endothelial-Lymphatic_EC-endothelial_cell_of_lymphatic_vessel-Lymphatic_EC_differentiating-Lymphatic_EC_differentiating_L.2.5.1.1|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.84e-06 | 183 | 101 | 6 | 4d16bfbadf2cd13008c35e23dd2b5b4ecf92ee11 | |
| ToppCell | 5'-Parenchyma_lung-Endothelial-Lymphatic_EC-endothelial_cell_of_lymphatic_vessel-Lymphatic_EC_differentiating|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 4.21e-06 | 186 | 101 | 6 | 40070d9cd20188ba49b32acfca9bc16256b38bf5 | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Non-neuronal-Macroglial-Astro-Astrocyte-Astro_L1-6_FGFR3_ETNPPL|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 4.34e-06 | 187 | 101 | 6 | 4d2115a05ec36dd179ca1d4a525f2d4501aea557 | |
| ToppCell | pdx-Tumor_cells-T5|Tumor_cells / Sample and Cell Type and Tumor Cluster (all cells) | 4.34e-06 | 187 | 101 | 6 | 7e376831a11ee72ed87abcdac631ca46ae29c250 | |
| ToppCell | droplet-Lung-1m-Endothelial-lymphatic_endothelial-lymphatic_endothelial_cell-lymphatic_endothelial_cell|1m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 4.48e-06 | 188 | 101 | 6 | dc52dd2957be3f40001f0a56f3d9ac9d66ea466e | |
| ToppCell | droplet-Lung-1m-Endothelial-lymphatic_endothelial|1m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 4.48e-06 | 188 | 101 | 6 | 2ef08313087e91985bcffc46c3798470cdeec49c | |
| ToppCell | droplet-Lung-1m-Endothelial-lymphatic_endothelial-lymphatic_endothelial_cell|1m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 4.48e-06 | 188 | 101 | 6 | 1f1604b6dc0a8ad0be3d9aac0bef448459c22465 | |
| ToppCell | facs-Pancreas-Endocrine-24m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.48e-06 | 188 | 101 | 6 | a91443aa8fa8fa87f7501c59219daa0305bd0bbf | |
| ToppCell | cellseq2-Endothelial-Endothelial_Vascular-Endothelial_large_blood_vessel-VEC|cellseq2 / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 4.62e-06 | 189 | 101 | 6 | bccb3481ffed597c845fe860da658505316105b5 | |
| ToppCell | Somatosensory_Cortex_(S1)-Non-neuronal|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 4.62e-06 | 189 | 101 | 6 | 42ab4cc5fbf8580841f31889446fe4499df1a464 | |
| ToppCell | primary_auditory_cortex_(A1C)-Non-neuronal|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 4.62e-06 | 189 | 101 | 6 | 37ecbd73408d462b47d7e5611f203143e08a2689 | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Non-neuronal|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 4.91e-06 | 191 | 101 | 6 | f3158cedf67e3b90aa94ea1f61c72c33aaa2d5ba | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Non-neuronal|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 4.91e-06 | 191 | 101 | 6 | a90c8ab2077e52bbc998457c85a1b9867f9c8c93 | |
| ToppCell | 367C-Endothelial_cells-Endothelial-F_(Lymphatics)|Endothelial_cells / Donor, Lineage, Cell class and subclass (all cells) | 5.06e-06 | 192 | 101 | 6 | 5e709c0714e8eba27e03a6def0544256bedb3ced | |
| ToppCell | PCW_05-06-Mesenchymal-Mesenchymal_fibroblastic-mes_chondroblast_(18)|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung | 5.06e-06 | 192 | 101 | 6 | d0649410cf5eacdb0c1dce70e37c7473ef5fddfa | |
| ToppCell | Primary_Motor_Cortex_(M1)-Non-neuronal-Macroglial-Astro-Astrocyte-Astro_L1-6_FGFR3_ETNPPL|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 5.06e-06 | 192 | 101 | 6 | 43beaac1de99b9c1a6dab4a450b4e81286987b64 | |
| ToppCell | 367C-Endothelial_cells-Endothelial-F_(Lymphatics)-|Endothelial_cells / Donor, Lineage, Cell class and subclass (all cells) | 5.06e-06 | 192 | 101 | 6 | 5f4f44f15d3a2846981e68296643a4634930a211 | |
| ToppCell | ILEUM-inflamed-(7)_Endothelial_cell-(7)_Lymphatics|(7)_Endothelial_cell / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2) | 5.06e-06 | 192 | 101 | 6 | d43caf42ec744e895137f31ef65a990e250669d2 | |
| ToppCell | Primary_Motor_Cortex_(M1)-Non-neuronal-Macroglial-Astro-Astrocyte|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 5.21e-06 | 193 | 101 | 6 | b03d908d4b8940927f72c76a1b0f237d13f39056 | |
| ToppCell | Primary_Motor_Cortex_(M1)-Non-neuronal-Macroglial-Astro|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 5.21e-06 | 193 | 101 | 6 | 40edc07b6e7f19f6ee885fa5af0b63ef1b0f2468 | |
| ToppCell | COPD-Endothelial-Lymphatic|Endothelial / Disease state, Lineage and Cell class | 5.52e-06 | 195 | 101 | 6 | e91ce548ae7224661ee5d2f2639794a5f69798ee | |
| ToppCell | Bronchial-NucSeq|Bronchial / Cell types per location group and 10X technology with lineage, and cell group designations | 5.69e-06 | 196 | 101 | 6 | ab53c742866945545a92e2e61850d63c80d9a2a6 | |
| ToppCell | Control-Endothelial-Lymphatic|Endothelial / Disease state, Lineage and Cell class | 5.69e-06 | 196 | 101 | 6 | e0cf617b0f5d9c3c19574f587a3d0ccbf93d8ca4 | |
| ToppCell | distal-Endothelial-Lymphatic|distal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 5.69e-06 | 196 | 101 | 6 | 3e8a20e1d163dcbd3bbd99fe179d54af02298af0 | |
| ToppCell | facs-Trachea-3m-Mesenchymal-myofibroblast-tracheobronchial_smooth_muscle_cell-smooth_muscle_cell_of_trachea_l34|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 5.86e-06 | 197 | 101 | 6 | 6e111ba16fc8adde782b3f7da250248cddf11228 | |
| ToppCell | facs-Trachea-3m-Mesenchymal-myofibroblast-tracheobronchial_smooth_muscle_cell|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 5.86e-06 | 197 | 101 | 6 | 4b6c0e028b9669c102df8e9dc63e284f8d5fd9ee | |
| ToppCell | facs-Trachea-3m-Mesenchymal-myofibroblast|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 5.86e-06 | 197 | 101 | 6 | ece0c17eb68f394b20e588c0b0626d3987a4dbbb | |
| ToppCell | Parenchymal-NucSeq|Parenchymal / Cell types per location group and 10X technology with lineage, and cell group designations | 6.03e-06 | 198 | 101 | 6 | 1996373bdccc55aac347d349bd22f6aad6d0c668 | |
| ToppCell | facs-Trachea-nan-3m-Mesenchymal-chondrocyte|Trachea / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.03e-06 | 198 | 101 | 6 | 71e847e8c24744d6df4a960348ad2ecf310373b4 | |
| ToppCell | droplet-Trachea|droplet / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.21e-06 | 199 | 101 | 6 | 1c7d30765ddb2291967da5d15664c6238c680c1d | |
| ToppCell | Bronchial-10x5prime-Stromal-Peri/Epineurial_|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 6.21e-06 | 199 | 101 | 6 | 45c3b853900d8c3d5965117d904e3714100138bc | |
| ToppCell | droplet-Trachea|droplet / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 6.21e-06 | 199 | 101 | 6 | b9038a1ccf3ef3123e2e39afbe6213c363437443 | |
| ToppCell | Frontal_cortex-Neuronal|Frontal_cortex / BrainAtlas - Mouse McCarroll V32 | 6.21e-06 | 199 | 101 | 6 | f88039d862f3bfa01dc39d2de4f3f548dc5a0e61 | |
| ToppCell | 368C-Myeloid-Dendritic-cDC_activated|Dendritic / Donor, Lineage, Cell class and subclass (all cells) | 3.72e-05 | 165 | 101 | 5 | 9d2bdc42c13c8c2a68889bec8612a1ce56f659fa | |
| ToppCell | Adult-Mesenchymal-chondrocyte-D175|Adult / Lineage, Cell type, age group and donor | 4.06e-05 | 168 | 101 | 5 | 14071b961c9bdb54a8259b12a88237b802cbde36 | |
| ToppCell | Control-Epithelial_cells-ECM-high_epithelial|Control / group, cell type (main and fine annotations) | 4.29e-05 | 170 | 101 | 5 | e2023d66e70983c87dacbd6181d3426488d1fc57 | |
| ToppCell | 3'-Child04-06-SmallIntestine-Mesenchymal-fibroblastic-mLTo|Child04-06 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 4.29e-05 | 170 | 101 | 5 | 7653f1205d4e62abe7e31b1d76f9bbd665e45667 | |
| ToppCell | Children_(3_yrs)-Endothelial-endothelial_cell_of_bronchial_vessel-D032|Children_(3_yrs) / Lineage, Cell type, age group and donor | 4.41e-05 | 171 | 101 | 5 | 1ae4b6a25bc9c1065cf5d95998ebcc70aee21ab5 | |
| ToppCell | 3'-Pediatric_IBD-SmallIntestine-Endothelial-lymphatic_endothelial-LEC4_(STAB2+)|Pediatric_IBD / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 4.54e-05 | 172 | 101 | 5 | 1bad7b19724e1b53ace7e05644215334c9f43910 | |
| ToppCell | P15-Mesenchymal-mesenchymal_fibroblast-tracheal_fibroblast|P15 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 4.92e-05 | 175 | 101 | 5 | 085cceb1fc2c4ae2f27e85cea5702defecc2cf44 | |
| ToppCell | P03-Mesenchymal-mesenchymal_fibroblast-tracheal_fibroblast|P03 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 5.34e-05 | 178 | 101 | 5 | 8591a40fced747ac16b3e8ebc7a22dfb3ad76da2 | |
| ToppCell | 5'-Adult-Distal_Rectal-Epithelial-goblet|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 5.34e-05 | 178 | 101 | 5 | 9099b47e0756d6a1b7ba1c6aa7b47c5425f649e0 | |
| ToppCell | 368C-Myeloid-Macrophage-SPP1+_Macrophage_3|368C / Donor, Lineage, Cell class and subclass (all cells) | 5.34e-05 | 178 | 101 | 5 | 536a601abcc60867949ea06e9aafb6c7b799b56b | |
| ToppCell | human_hepatoblastoma-Tumor_cells-T6|Tumor_cells / Sample and Cell Type and Tumor Cluster (all cells) | 5.48e-05 | 179 | 101 | 5 | 14fc8ccb6b215063d747643f47d780d2b237eb67 | |
| ToppCell | 5'-Adult-LargeIntestine-Mesenchymal-mesothelial_cell|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 5.78e-05 | 181 | 101 | 5 | 65eaa9bc1022bcf0c5f0f92c07a2cbbf11f9b59c | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Renal_corpuscle_epithelial_cell-glomerular_visceral_epithelial_cell-Podocyte|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 5.78e-05 | 181 | 101 | 5 | 5bf7aa43f6e6ecce15c95928b91195544d6928c4 | |
| ToppCell | 5'-Adult-LargeIntestine-Mesenchymal-mesothelial_cell-Mesothelium_(PRG4+)|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 5.78e-05 | 181 | 101 | 5 | eaac7d58117eddfff06b25521efc431c1351d592 | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Renal_corpuscle_epithelial_cell-glomerular_visceral_epithelial_cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 5.78e-05 | 181 | 101 | 5 | 8e751f5d7cd2d328ec0196d874e8a507e8c4e1a9 | |
| ToppCell | Somatosensory_Cortex_(S1)-Non-neuronal-Macroglial-Oligo-OPC|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 5.93e-05 | 182 | 101 | 5 | 8a8b08ac4bb3cba3541dbe234e088703842285b9 | |
| ToppCell | Somatosensory_Cortex_(S1)-Non-neuronal-Macroglial-Oligo-OPC-OPC_L1-6_MYT1|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 5.93e-05 | 182 | 101 | 5 | e36766309c4d96a90d213ce37d3acef1029a3fdc | |
| ToppCell | 5'-GW_trimst-2-LargeIntestine-Endothelial-lymphatic_endothelial|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 6.09e-05 | 183 | 101 | 5 | 764ea07621f77fbd13a877aed5806ae2b3dfb43e | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-thymocyte|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.25e-05 | 184 | 101 | 5 | 2cbed6462fea2622871bb7e49b0df3d984239281 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.25e-05 | 184 | 101 | 5 | ea7a7e2bac46d4d2c31a5d576b38a032b5335062 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-proliferating_thymocyte;_DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.25e-05 | 184 | 101 | 5 | 2b19a8c5f823e00812908b23e66bb4e563278aff | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Non-neuronal-Macroglial-Oligo-OPC-OPC_L1-6_MYT1|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 6.41e-05 | 185 | 101 | 5 | 2e1766f1a972fecd670daaaf7eb2d3a404f121e7 | |
| ToppCell | ILEUM-inflamed-(7)_Lymphatics|inflamed / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2) | 6.41e-05 | 185 | 101 | 5 | d711dd2e91cfee723dae1ccb2b910b8cf3becc3b | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Non-neuronal-Macroglial-Oligo-OPC|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 6.41e-05 | 185 | 101 | 5 | 7aaa8335b40927e3e8fdcede807cd521fc213a0d | |
| ToppCell | droplet-Lung-18m-Endothelial-arterial_endothelial-pulmonary_artery_endothelial_cell-pulmonary_artery_endothelial_cell_l25|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 6.57e-05 | 186 | 101 | 5 | 9c7924875f70420720149287c500b4dfa8d24673 | |
| ToppCell | LPS-IL1RA+antiTNF-Epithelial_alveolar-AT_1-Differentiating_AT1|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 6.57e-05 | 186 | 101 | 5 | 3aebe163799109ffc67e4e10ee47c2dd0886a92c | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Degenerative_Proximal_Tubule_Epithelial_Cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 6.74e-05 | 187 | 101 | 5 | 3ae3b8de1a195d4d5057cf3c64fcdb5f48681ce5 | |
| ToppCell | COVID-19-kidney-Fibroblast-1|COVID-19 / Disease (COVID-19 only), tissue and cell type | 6.74e-05 | 187 | 101 | 5 | 76bfe8c42430a230a8bdf299575c444fb7780f24 | |
| ToppCell | IPF-Epithelial-Aberrant_Basaloid|IPF / Disease state, Lineage and Cell class | 6.74e-05 | 187 | 101 | 5 | 19d6a404fc3651d98a93e3848e372df51a239c57 | |
| ToppCell | LPS_only-Epithelial_alveolar-AT_1|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 6.74e-05 | 187 | 101 | 5 | ff26a533d310126521efe1d05cf8b9d32e524550 | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Non-neuronal-Macroglial-Astro-Astrocyte-Astro_L1-6_FGFR3_ETNPPL|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 6.74e-05 | 187 | 101 | 5 | 93c78fc7f126132eb84feb47be2c4e8c568b9e91 | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-myofibroblast_cell|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 6.74e-05 | 187 | 101 | 5 | c104fbfef2d0bef64077ac721edf2379fd59d547 | |
| ToppCell | facs-Brain_Non-Myeloid-Hippocampus-24m-Neuronal-neuron|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.74e-05 | 187 | 101 | 5 | e04a84989d624378141042768383b9c846901f2d | |
| ToppCell | facs-Brain_Non-Myeloid-Hippocampus-24m-Neuronal-nan|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.74e-05 | 187 | 101 | 5 | 24cc03c748e15f7ef0e6509ca5a6ca583fb9c573 | |
| ToppCell | facs-Brain_Non-Myeloid-Hippocampus-24m-Neuronal|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.74e-05 | 187 | 101 | 5 | 2f153b203fe79f206319603cf94d3a03ab49a05d | |
| ToppCell | facs-Heart-RA-3m-Endothelial-endocardial_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.91e-05 | 188 | 101 | 5 | 4ddb11a90bf3baa7237bde304db44dfcc56aed52 | |
| ToppCell | Fetal_29-31_weeks-Epithelial-alveolar_epithelial_cell_type_1|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 6.91e-05 | 188 | 101 | 5 | eea652bab161f19148a883e7e3fe2523b36b3cea | |
| ToppCell | facs-Heart-RA-3m-Endothelial-endothelial_cell_of_endocardium|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.91e-05 | 188 | 101 | 5 | e47e66906922d5c69b1aafe28face0787d3fc563 | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Non-neuronal-Macroglial|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 6.91e-05 | 188 | 101 | 5 | 505b6b4277d7dea87aee27191d0acca67928b8e6 | |
| ToppCell | droplet-Lung-nan-18m-Endothelial-Artery_endothelial_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.91e-05 | 188 | 101 | 5 | 405efea75233ecf70f7d19b630230798d817b7f2 | |
| ToppCell | Adult-Epithelial-alveolar_epithelial_cell_type_2-D175|Adult / Lineage, Cell type, age group and donor | 6.91e-05 | 188 | 101 | 5 | ec38def1fdbb34ed9b30244806975bd5a4370164 | |
| ToppCell | E12.5-Mesenchymal-mesenchymal_fibroblast-tracheal_fibroblast|E12.5 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 6.91e-05 | 188 | 101 | 5 | 9b95730ddd13eb4624321bab3ab4989414977ca3 | |
| ToppCell | Children_(3_yrs)-Endothelial-endothelial_cell_of_lymph_vessel-D139|Children_(3_yrs) / Lineage, Cell type, age group and donor | 6.91e-05 | 188 | 101 | 5 | aeecbc057dc823f8fcea8a98f18d213bacc7f4db | |
| ToppCell | 3'-Adult-LargeIntestine-Mesenchymal-myocytic|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 7.09e-05 | 189 | 101 | 5 | f7e2ee5047792ab9ef6472fa88e2d193cdea6fa0 | |
| ToppCell | ASK428-Epithelial-Transformed_epithelium|ASK428 / Donor, Lineage and Cell class of Lung cells from Dropseq | 7.09e-05 | 189 | 101 | 5 | 87189275234b5d59484c58acbb14a09903f2b578 | |
| ToppCell | COVID-19-lung-Secretory|lung / Disease (COVID-19 only), tissue and cell type | 7.09e-05 | 189 | 101 | 5 | 84d48e3ed25bebb8bb8074b3a2c5e2e88cff7f25 | |
| ToppCell | 3'-Adult-LargeIntestine-Mesenchymal-myocytic-myofibroblast_(RSPO2+)|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 7.09e-05 | 189 | 101 | 5 | 63449d9f1e78ff2bc8786eb88a0d177fe30c7f4d | |
| ToppCell | droplet-Heart-nan-24m-Endothelial-endocardial_endothelial_cells|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.09e-05 | 189 | 101 | 5 | 1137583e21d874c201c20581ba1995e2bfa3de59 | |
| ToppCell | droplet-Heart-nan-3m-Endothelial-endocardial_endothelial_cells|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.09e-05 | 189 | 101 | 5 | fb2253b8463d08b3d28e952a31a23dea2c2d986b | |
| ToppCell | IPF-Epithelial-Basal|IPF / Disease state, Lineage and Cell class | 7.27e-05 | 190 | 101 | 5 | ea19e9ce954f2dfde97388db9695325cd92ab88f | |
| ToppCell | droplet-Heart-nan-24m-Endothelial-endocardial_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.27e-05 | 190 | 101 | 5 | 7068754c29f63a331e2b6c54715f3b26f37ad32b | |
| Drug | Ceforanide [60925-61-3]; Down 200; 7.6uM; MCF7; HT_HG-U133A | 2.04e-06 | 191 | 100 | 8 | 5351_DN | |
| Drug | Nifenazone [2139-47-1]; Down 200; 13uM; PC3; HT_HG-U133A | 2.38e-06 | 195 | 100 | 8 | 2122_DN | |
| Drug | Thiocolchicoside [602-41-5]; Up 200; 7uM; HL60; HG-U133A | 2.57e-06 | 197 | 100 | 8 | 1726_UP | |
| Drug | Dimenhydrinate [523-87-5]; Down 200; 8.6uM; PC3; HT_HG-U133A | 2.67e-06 | 198 | 100 | 8 | 6352_DN | |
| Drug | 5253409; Up 200; 17uM; MCF7; HT_HG-U133A_EA | 2.17e-05 | 191 | 100 | 7 | 844_UP | |
| Drug | Methylhydantoin-5-(L) [40856-73-3]; Down 200; 35uM; MCF7; HT_HG-U133A | 2.32e-05 | 193 | 100 | 7 | 3378_DN | |
| Drug | semustine; Up 200; 100uM; MCF7; HT_HG-U133A | 2.40e-05 | 194 | 100 | 7 | 7487_UP | |
| Drug | GSK-3 Inhibitor IX; Up 200; 0.5uM; MCF7; HT_HG-U133A | 2.40e-05 | 194 | 100 | 7 | 7044_UP | |
| Drug | Benzydamine hydrochloride [132-69-4]; Down 200; 11.6uM; MCF7; HT_HG-U133A | 2.40e-05 | 194 | 100 | 7 | 3169_DN | |
| Drug | Methionine sulfoximine (L) [15985-39-4]; Down 200; 22.2uM; MCF7; HT_HG-U133A | 2.40e-05 | 194 | 100 | 7 | 2831_DN | |
| Drug | Amiodarone hydrochloride [19774-82-4]; Up 200; 5.8uM; MCF7; HT_HG-U133A | 2.56e-05 | 196 | 100 | 7 | 5253_UP | |
| Drug | Ursolic acid [77-52-1]; Down 200; 8.8uM; MCF7; HT_HG-U133A | 2.56e-05 | 196 | 100 | 7 | 7181_DN | |
| Drug | Zuclopenthixol hydrochloride [633-59-0]; Down 200; 9.2uM; MCF7; HT_HG-U133A | 2.56e-05 | 196 | 100 | 7 | 7356_DN | |
| Drug | Aminocaproic acid [60-32-2]; Up 200; 30.4uM; MCF7; HT_HG-U133A | 2.56e-05 | 196 | 100 | 7 | 6501_UP | |
| Drug | GSK-3beta Inhibitor VIII; Up 200; 10uM; MCF7; HT_HG-U133A | 2.56e-05 | 196 | 100 | 7 | 7092_UP | |
| Drug | Pivmecillinam hydrochloride [32887-03-9]; Down 200; 8.4uM; MCF7; HT_HG-U133A | 2.56e-05 | 196 | 100 | 7 | 6014_DN | |
| Drug | Alcuronium chloride [15180-03-7]; Down 200; 5.4uM; MCF7; HT_HG-U133A | 2.56e-05 | 196 | 100 | 7 | 4409_DN | |
| Drug | clozapine; Down 200; 10uM; MCF7; HT_HG-U133A | 2.65e-05 | 197 | 100 | 7 | 5226_DN | |
| Drug | vinblastine sulfate; Up 200; 0.1uM; MCF7; HT_HG-U133A | 2.65e-05 | 197 | 100 | 7 | 7551_UP | |
| Drug | thioridazine hydrochloride; Down 200; 10uM; MCF7; HT_HG-U133A | 2.65e-05 | 197 | 100 | 7 | 5227_DN | |
| Drug | Hydralazine hydrochloride [304-20-1]; Down 200; 20.4uM; MCF7; HT_HG-U133A | 2.74e-05 | 198 | 100 | 7 | 3621_DN | |
| Drug | Megestrol acetate [595-33-5]; Down 200; 10.4uM; MCF7; HT_HG-U133A | 2.74e-05 | 198 | 100 | 7 | 5013_DN | |
| Drug | Fipexide hydrochloride [34161-23-4]; Down 200; 9.4uM; HL60; HG-U133A | 2.74e-05 | 198 | 100 | 7 | 1560_DN | |
| Drug | haloperidol; Down 200; 10uM; MCF7; HT_HG-U133A_EA | 2.74e-05 | 198 | 100 | 7 | 983_DN | |
| Drug | Dicumarol [66-76-2]; Down 200; 11.8uM; MCF7; HT_HG-U133A | 2.74e-05 | 198 | 100 | 7 | 3423_DN | |
| Drug | Flecainide acetate [54143-56-5]; Down 200; 8.4uM; MCF7; HT_HG-U133A | 2.74e-05 | 198 | 100 | 7 | 3418_DN | |
| Drug | Sulfasalazine [599-79-1]; Up 200; 10uM; HL60; HG-U133A | 2.74e-05 | 198 | 100 | 7 | 1733_UP | |
| Drug | Phenelzine sulfate [156-51-4]; Up 200; 17uM; MCF7; HT_HG-U133A | 2.74e-05 | 198 | 100 | 7 | 2319_UP | |
| Drug | Carteolol hydrochloride [51781-21-6]; Down 200; 12.2uM; MCF7; HT_HG-U133A | 2.92e-05 | 200 | 100 | 7 | 3276_DN | |
| Drug | Benzylpenicillin sodium [69-57-8]; Down 200; 11.2uM; MCF7; HT_HG-U133A | 2.92e-05 | 200 | 100 | 7 | 3577_DN | |
| Drug | thioridazine hydrochloride; Up 200; 10uM; MCF7; HT_HG-U133A_EA | 6.59e-05 | 156 | 100 | 6 | 1010_UP | |
| Drug | Chloroprene | RAPH1 CARMIL1 WIPF3 ETV5 POGZ TNFRSF21 DOCK5 NCOR1 RBM12 CD5 SATB1 ZFHX4 SETD5 BRD4 STON2 ERRFI1 TRAK2 | 7.55e-05 | 1348 | 100 | 17 | ctd:D002737 |
| Drug | pyrvinium pamoate; Up 200; 1.25uM; MCF7; HT_HG-U133A_EA | 1.06e-04 | 170 | 100 | 6 | 978_UP | |
| Drug | Cephaeline dihydrochloride heptahydrate [6487-30-5]; Down 200; 6uM; MCF7; HT_HG-U133A | 1.28e-04 | 176 | 100 | 6 | 5612_DN | |
| Drug | felodipine; Up 200; 10uM; MCF7; HT_HG-U133A_EA | 1.54e-04 | 182 | 100 | 6 | 848_UP | |
| Drug | Terfenadine [50679-08-8]; Down 200; 8.4uM; HL60; HG-U133A | 1.89e-04 | 189 | 100 | 6 | 1381_DN | |
| Drug | Strophanthidin [66-28-4]; Down 200; 9.8uM; HL60; HT_HG-U133A | 1.94e-04 | 190 | 100 | 6 | 2525_DN | |
| Drug | Syrosingopine [84-36-6]; Down 200; 6uM; MCF7; HT_HG-U133A | 1.94e-04 | 190 | 100 | 6 | 6213_DN | |
| Drug | indomethacin, USP; Up 200; 100uM; PC3; HG-U133A | 2.05e-04 | 192 | 100 | 6 | 452_UP | |
| Drug | Dimethisoquin hydrochloride [2773-92-4]; Up 200; 13uM; MCF7; HT_HG-U133A | 2.05e-04 | 192 | 100 | 6 | 2807_UP | |
| Drug | Muramic acid, N-acetyl [10597-89-4]; Up 200; 13.6uM; MCF7; HT_HG-U133A | 2.11e-04 | 193 | 100 | 6 | 3262_UP | |
| Drug | Metergoline [17692-51-2]; Down 200; 10uM; MCF7; HT_HG-U133A | 2.11e-04 | 193 | 100 | 6 | 3221_DN | |
| Drug | LY294002; Up 200; 10uM; MCF7; HT_HG-U133A | 2.11e-04 | 193 | 100 | 6 | 5965_UP | |
| Drug | Isoquinoline, 6,7-dimethoxy-1-methyl-1,2,3,4-tetrahydro, hydrochloride; Down 200; 16.4uM; MCF7; HT_HG-U133A | 2.17e-04 | 194 | 100 | 6 | 2824_DN | |
| Drug | 0317956-0000 [391210-11-0]; Down 200; 1uM; MCF7; HT_HG-U133A | 2.17e-04 | 194 | 100 | 6 | 3969_DN | |
| Drug | Bromperidol [10457-90-6]; Down 200; 9.6uM; MCF7; HT_HG-U133A | 2.17e-04 | 194 | 100 | 6 | 7457_DN | |
| Drug | haloperidol; Down 200; 10uM; HL60; HT_HG-U133A | 2.17e-04 | 194 | 100 | 6 | 1185_DN | |
| Drug | Albendazole [54965-21-8]; Down 200; 15uM; HL60; HG-U133A | 2.17e-04 | 194 | 100 | 6 | 1547_DN | |
| Drug | Leucomisine [17946-87-1]; Down 200; 16.2uM; MCF7; HT_HG-U133A | 2.17e-04 | 194 | 100 | 6 | 6767_DN | |
| Drug | Acetylsalicylsalicylic acid [530-75-6]; Down 200; 13.4uM; MCF7; HT_HG-U133A | 2.17e-04 | 194 | 100 | 6 | 6778_DN | |
| Drug | Harmol hydrochloride monohydrate [40580-83-4]; Down 200; 15.8uM; MCF7; HT_HG-U133A | 2.17e-04 | 194 | 100 | 6 | 2900_DN | |
| Drug | (+)-Isoproterenol (+)-bitartrate salt [14638-70-1]; Down 200; 11uM; MCF7; HT_HG-U133A | 2.17e-04 | 194 | 100 | 6 | 3384_DN | |
| Drug | DO 897/99; Down 200; 8.2uM; HL60; HG-U133A | 2.17e-04 | 194 | 100 | 6 | 1728_DN | |
| Drug | Piribedil hydrochloride [78213-63-5]; Down 200; 12uM; MCF7; HT_HG-U133A | 2.23e-04 | 195 | 100 | 6 | 3512_DN | |
| Drug | Spironolactone [52-01-7]; Down 200; 9.6uM; MCF7; HT_HG-U133A | 2.23e-04 | 195 | 100 | 6 | 6255_DN | |
| Drug | Tribenoside [10310-32-4]; Down 200; 8.4uM; HL60; HT_HG-U133A | 2.23e-04 | 195 | 100 | 6 | 2946_DN | |
| Drug | Tacrine hydrochloride hydrate [1684-40-8]; Up 200; 15.8uM; MCF7; HT_HG-U133A | 2.23e-04 | 195 | 100 | 6 | 5297_UP | |
| Drug | Oxprenolol hydrochloride [6452-73-9]; Down 200; 13.2uM; MCF7; HT_HG-U133A | 2.23e-04 | 195 | 100 | 6 | 7225_DN | |
| Drug | Cloperastine hydrochloride [14984-68-0]; Down 200; 11uM; MCF7; HT_HG-U133A | 2.23e-04 | 195 | 100 | 6 | 3408_DN | |
| Drug | Methyldopa (L,-) [555-30-6]; Up 200; 19uM; HL60; HG-U133A | 2.23e-04 | 195 | 100 | 6 | 1619_UP | |
| Drug | Diethylcarbamazine citrate [1642-54-2]; Up 200; 10.2uM; HL60; HT_HG-U133A | 2.23e-04 | 195 | 100 | 6 | 2394_UP | |
| Drug | Cyclopenthiazide [742-20-1]; Up 200; 10.6uM; MCF7; HT_HG-U133A | 2.23e-04 | 195 | 100 | 6 | 4813_UP | |
| Drug | Spaglumic acid [4910-46-7]; Down 200; 13.2uM; HL60; HT_HG-U133A | 2.23e-04 | 195 | 100 | 6 | 2962_DN | |
| Drug | Methyldopate hydrochloride [2508-79-4]; Down 200; 14.6uM; MCF7; HT_HG-U133A | 2.30e-04 | 196 | 100 | 6 | 7360_DN | |
| Drug | Debrisoquin sulfate [581-88-4]; Up 200; 9uM; MCF7; HT_HG-U133A | 2.30e-04 | 196 | 100 | 6 | 5288_UP | |
| Drug | H-89, Dihydrochloride; Down 200; 0.5uM; PC3; HT_HG-U133A | 2.30e-04 | 196 | 100 | 6 | 6873_DN | |
| Drug | Canrenoic acid potassium salt [2181-04-6]; Down 200; 10uM; PC3; HT_HG-U133A | 2.30e-04 | 196 | 100 | 6 | 2065_DN | |
| Drug | Dicloxacillin sodium salt [13412-64-1]; Down 200; 8.2uM; PC3; HT_HG-U133A | 2.30e-04 | 196 | 100 | 6 | 6666_DN | |
| Drug | CP-863187 [668981-07-5]; Up 200; 10uM; PC3; HT_HG-U133A | 2.30e-04 | 196 | 100 | 6 | 7512_UP | |
| Drug | Carisoprodol [78-44-4]; Down 200; 15.4uM; PC3; HT_HG-U133A | 2.30e-04 | 196 | 100 | 6 | 6610_DN | |
| Drug | Napelline [5008-52-6]; Up 200; 11.2uM; MCF7; HT_HG-U133A | 2.30e-04 | 196 | 100 | 6 | 6824_UP | |
| Drug | Tocopherol (R,S) [10191-41-0]; Up 200; 9.2uM; MCF7; HT_HG-U133A | 2.30e-04 | 196 | 100 | 6 | 3256_UP | |
| Drug | Meglumine [6284-40-8]; Down 200; 20.4uM; MCF7; HT_HG-U133A | 2.30e-04 | 196 | 100 | 6 | 6445_DN | |
| Drug | Terconazole [67915-31-5]; Down 200; 7.6uM; MCF7; HT_HG-U133A | 2.30e-04 | 196 | 100 | 6 | 4407_DN | |
| Drug | rosiglitazone; Up 200; 10uM; MCF7; HT_HG-U133A | 2.30e-04 | 196 | 100 | 6 | 1658_UP | |
| Drug | Aminopurine, 6-benzyl [1214-39-7]; Down 200; 17.8uM; MCF7; HT_HG-U133A | 2.30e-04 | 196 | 100 | 6 | 3623_DN | |
| Drug | Phenindione [83-12-5]; Up 200; 18uM; HL60; HG-U133A | 2.36e-04 | 197 | 100 | 6 | 1718_UP | |
| Drug | Gallamine triethiodide [65-29-2]; Up 200; 4.4uM; PC3; HT_HG-U133A | 2.36e-04 | 197 | 100 | 6 | 2059_UP | |
| Drug | Etofylline [519-37-9]; Down 200; 17.8uM; PC3; HT_HG-U133A | 2.36e-04 | 197 | 100 | 6 | 2093_DN | |
| Drug | TTNPB; Up 200; 0.1uM; PC3; HG-U133A | 2.36e-04 | 197 | 100 | 6 | 451_UP | |
| Drug | Sulfamonomethoxine [1220-83-3]; Up 200; 14.2uM; PC3; HT_HG-U133A | 2.36e-04 | 197 | 100 | 6 | 5843_UP | |
| Drug | STOCK1N-35696; Up 200; 15uM; PC3; HT_HG-U133A | 2.36e-04 | 197 | 100 | 6 | 6564_UP | |
| Drug | N6-methyladenosine [1867-73-8]; Down 200; 14.2uM; MCF7; HT_HG-U133A | 2.36e-04 | 197 | 100 | 6 | 5332_DN | |
| Drug | Sulfaquinoxaline sodium salt [967-80-6]; Down 200; 12.4uM; MCF7; HT_HG-U133A | 2.36e-04 | 197 | 100 | 6 | 6788_DN | |
| Drug | Acetaminophen [103-90-2]; Down 200; 26.4uM; MCF7; HT_HG-U133A | 2.36e-04 | 197 | 100 | 6 | 3364_DN | |
| Drug | Yohimbine hydrochloride [65-19-0]; Up 200; 10.2uM; HL60; HG-U133A | 2.36e-04 | 197 | 100 | 6 | 1763_UP | |
| Drug | Dantrolene sodium salt [14663-23-1]; Down 200; 11.8uM; PC3; HT_HG-U133A | 2.36e-04 | 197 | 100 | 6 | 3786_DN | |
| Drug | Panthenol (D) [81-13-0]; Down 200; 19.4uM; MCF7; HT_HG-U133A | 2.36e-04 | 197 | 100 | 6 | 1680_DN | |
| Drug | Orlistat; Down 200; 10uM; MCF7; HT_HG-U133A | 2.36e-04 | 197 | 100 | 6 | 6383_DN | |
| Drug | U-62066 [87151-85-7]; Down 200; 1uM; PC3; HT_HG-U133A | 2.36e-04 | 197 | 100 | 6 | 3818_DN | |
| Drug | Triamterene [396-01-0]; Down 200; 15.8uM; MCF7; HT_HG-U133A | 2.36e-04 | 197 | 100 | 6 | 1697_DN | |
| Drug | Amidopyrine [58-15-1]; Down 200; 17.2uM; PC3; HT_HG-U133A | 2.36e-04 | 197 | 100 | 6 | 2060_DN | |
| Drug | Scopolamine hydrochloride [55-16-3]; Up 200; 11.8uM; MCF7; HT_HG-U133A | 2.36e-04 | 197 | 100 | 6 | 3357_UP | |
| Drug | Molsidomine [25717-80-0]; Down 200; 16.6uM; PC3; HT_HG-U133A | 2.36e-04 | 197 | 100 | 6 | 6325_DN | |
| Drug | Fenbufen [36330-85-5]; Up 200; 15.8uM; MCF7; HT_HG-U133A | 2.36e-04 | 197 | 100 | 6 | 2308_UP | |
| Drug | Mimosine [500-44-7]; Up 200; 20.2uM; MCF7; HT_HG-U133A | 2.36e-04 | 197 | 100 | 6 | 5302_UP | |
| Drug | Ticarcillin sodium [4697-14-7]; Up 200; 9.4uM; PC3; HT_HG-U133A | 2.43e-04 | 198 | 100 | 6 | 5829_UP | |
| Drug | 2-propylpentanoic acid; Down 200; 1000uM; MCF7; HT_HG-U133A | 2.43e-04 | 198 | 100 | 6 | 6929_DN | |
| Drug | Lysergol [602-85-7]; Down 200; 15.8uM; MCF7; HT_HG-U133A | 2.43e-04 | 198 | 100 | 6 | 3261_DN | |
| Drug | HA-1077 dihydrochloride; Up 200; 10uM; MCF7; HG-U133A | 2.43e-04 | 198 | 100 | 6 | 343_UP | |
| Disease | cerebral palsy (implicated_via_orthology) | 2.70e-13 | 10 | 100 | 6 | DOID:1969 (implicated_via_orthology) | |
| Disease | platelet crit | DEAF1 NHSL2 CARMIL1 LAMA5 MECOM ZC3H18 MEF2D ATXN2 PRPF3 CBX6 STON2 RPRD2 PKN3 | 2.01e-05 | 952 | 100 | 13 | EFO_0007985 |
| Disease | colorectal adenocarcinoma (is_implicated_in) | 2.28e-04 | 35 | 100 | 3 | DOID:0050861 (is_implicated_in) | |
| Disease | cocaine use disorder, social environment measurement | 3.14e-04 | 8 | 100 | 2 | EFO_0010445, EFO_0010552 | |
| Disease | Cornelia De Lange Syndrome | 3.14e-04 | 8 | 100 | 2 | C0270972 | |
| Disease | idiopathic pulmonary fibrosis (is_implicated_in) | 4.03e-04 | 9 | 100 | 2 | DOID:0050156 (is_implicated_in) | |
| Disease | left ventricular systolic function measurement | 4.52e-04 | 44 | 100 | 3 | EFO_0008206 | |
| Disease | diastolic blood pressure, systolic blood pressure | 4.61e-04 | 670 | 100 | 9 | EFO_0006335, EFO_0006336 | |
| Disease | multiple myeloma | 5.83e-04 | 112 | 100 | 4 | EFO_0001378 | |
| Disease | extracellular matrix protein 1 measurement | 8.66e-04 | 13 | 100 | 2 | EFO_0008126 | |
| Disease | age at menarche | 9.46e-04 | 594 | 100 | 8 | EFO_0004703 | |
| Disease | vital capacity | PCLO MECOM TRIM66 NCOR1 BRAF BRD4 ERRFI1 RPRD2 FLRT2 ADGRL2 PC AGAP1 | 9.72e-04 | 1236 | 100 | 12 | EFO_0004312 |
| Disease | Prostatic Neoplasms | 1.19e-03 | 616 | 100 | 8 | C0033578 | |
| Disease | Malignant neoplasm of prostate | 1.19e-03 | 616 | 100 | 8 | C0376358 | |
| Disease | forced expiratory volume | 1.46e-03 | 789 | 100 | 9 | EFO_0004314 | |
| Disease | Dystonia, Limb | 1.50e-03 | 17 | 100 | 2 | C0751093 | |
| Disease | Dystonia, Diurnal | 1.50e-03 | 17 | 100 | 2 | C0393610 | |
| Disease | Dystonia, Paroxysmal | 1.68e-03 | 18 | 100 | 2 | C0393588 | |
| Disease | body mass index, high density lipoprotein cholesterol measurement | 1.87e-03 | 19 | 100 | 2 | EFO_0004340, EFO_0004612 | |
| Disease | Retinitis pigmentosa | 2.06e-03 | 74 | 100 | 3 | cv:C0035334 | |
| Disease | white matter microstructure measurement | 2.15e-03 | 390 | 100 | 6 | EFO_0005674 | |
| Disease | otitis media (implicated_via_orthology) | 2.51e-03 | 22 | 100 | 2 | DOID:10754 (implicated_via_orthology) | |
| Disease | Moderate albuminuria | 2.57e-03 | 80 | 100 | 3 | HP_0012594 | |
| Disease | pulse pressure measurement | WIPF1 MAP1B RAPH1 CARMIL1 COL27A1 LAMA5 POGZ SRCAP TRIM66 ZFHX4 PLEKHA7 GABRA6 | 2.63e-03 | 1392 | 100 | 12 | EFO_0005763 |
| Disease | Autism Spectrum Disorders | 3.05e-03 | 85 | 100 | 3 | C1510586 | |
| Disease | Glioma | 3.26e-03 | 87 | 100 | 3 | C0017638 | |
| Disease | left ventricular structural measurement | 3.36e-03 | 88 | 100 | 3 | EFO_0008205 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| PSISSTTSPKLNPPP | 356 | Q96P64 | |
| LTSPSPSKSIPIPQP | 331 | P15056 | |
| PSISSTTSPKLDPPP | 506 | Q9UPQ3 | |
| ISSTTSPKLNPPPSP | 426 | Q5VTM2 | |
| TPPKLLPETVSPSAP | 291 | O95503 | |
| PTPLLPSVKVQSQPP | 941 | O60885 | |
| QKTTPPTTRPPPTTT | 136 | P06127 | |
| PPPAVSTTKIPPITN | 446 | O95490 | |
| PTLPSSSPVPIPVSL | 1246 | Q9C0C7 | |
| TPPTPTTSKLPTIPD | 396 | O43155 | |
| PSISSTTSPKLNPPP | 356 | Q5VW22 | |
| STPGTAPPPKVLTSP | 4271 | Q9HC84 | |
| APPPKVLTSPATTPT | 4276 | Q9HC84 | |
| THPPPQTLPRSKSPS | 401 | Q9NTZ6 | |
| QAPPKPLVTIPAPTS | 776 | Q70E73 | |
| PLPKPSSTTPTPLVS | 1191 | Q2KHR3 | |
| PVPSKPPVTPATSQD | 756 | Q03112 | |
| SCLPPEPPKTPVSSL | 196 | Q5HY64 | |
| SPSLSPSPPSPLEKT | 1256 | P46821 | |
| FSQPKPSTTPTSPRP | 926 | Q99700 | |
| KVPVPPPVPTVSLTS | 1991 | Q5HYC2 | |
| TSPPSPPLPSTVQSK | 3921 | Q2LD37 | |
| SQTRLPPTPASKPLP | 336 | Q15653 | |
| PSLPSPSKPPIQQPT | 296 | Q9Y6V0 | |
| LTTTPLPPSITPPTF | 1756 | Q02817 | |
| SPTPTPSKSTPTPSK | 4381 | Q02817 | |
| PKTSPQSAPPSSPLS | 481 | Q6ZU69 | |
| PKTSPQSAPPSSPLS | 211 | Q63HN1 | |
| PPRSAKPLSTSPSIP | 536 | Q9H706 | |
| LPVQPAKLTPRSTPP | 96 | A8MQ11 | |
| SSPLPPPVAVRKPST | 61 | Q14863 | |
| SQVTSTPISKPPPPL | 111 | Q14678 | |
| PELLKSTLPPPSTTP | 361 | Q99583 | |
| PKPPPASQPSLVSTV | 336 | Q71SY5 | |
| ILQSTPVTPPPLSPA | 396 | Q16445 | |
| FKPLTPPTTPLSPTH | 131 | P41161 | |
| KQPPLPPTISPTAPT | 2216 | Q9UMN6 | |
| AVPLQPPPPLTSASK | 3011 | O15230 | |
| SKRQLTPLPPSAPPS | 901 | E5RHQ5 | |
| TPSKRQLTPLPPSAP | 941 | E5RHQ5 | |
| ATKFPPEITVTPPTP | 2141 | Q9Y6J0 | |
| LQSPSAVSTPPPLPK | 216 | Q16254 | |
| KSPLHPIPASPTSPQ | 1861 | Q8IZD9 | |
| TPLSPPPLTPKATRT | 1786 | Q9H7D0 | |
| TSLPALAVPPPTPTK | 421 | O75398 | |
| TTPKATVVPLPTLPP | 171 | Q6ZNA5 | |
| QTPKTPTTPLPQTPT | 451 | Q8WU20 | |
| PPTPIPTSASKLTFP | 1736 | O75417 | |
| PALAPKPTSQTPPAS | 961 | Q6ZU35 | |
| PSISSTTIPKLNPPP | 356 | Q5VUJ5 | |
| RPLPPTTSSSKKPIP | 441 | Q8IZC6 | |
| STSTIPAPPPITPKS | 676 | Q6PJG2 | |
| PTPTPPTRKTPESFL | 461 | Q9Y6I3 | |
| LSPEPPKTPVSSLRP | 211 | Q5JRC9 | |
| TPTSPKPLLQSPKPS | 1251 | Q5VZK9 | |
| SAKITSLPPPPPTLF | 161 | Q9C0D2 | |
| TPPLPKPVNTSLSPS | 426 | Q5VT52 | |
| PPPVKVSSEPPTQAT | 156 | O95104 | |
| SFISPPTPQPKTPSS | 161 | O43395 | |
| VIPAKSPPPPTHSTQ | 246 | Q14814 | |
| SPPVSPRVLSPPTTK | 1031 | A6NGG8 | |
| LLPPCSSPSTISPPK | 461 | Q6P5Z2 | |
| KPASSSLPSSPPPQL | 41 | Q99567 | |
| SPLSPSPIPSPNAKL | 516 | O75509 | |
| PVVPERKSSLPPTSP | 746 | Q5HYW2 | |
| LSPKPPTRSPSPPTQ | 666 | Q68EM7 | |
| PSSTPIPALSPPTKV | 436 | Q7Z3K3 | |
| RPPPPLIPSSKTTVA | 1031 | O75376 | |
| PVPSLSTSESKPPPQ | 851 | Q6IQ23 | |
| LSPVTPPPPNSGSKS | 851 | Q9C0A6 | |
| VNSSSETPPPLPPKS | 316 | A6NGB9 | |
| SQGPPTPPTTPKTDV | 231 | P48436 | |
| TSRPPTPTLSLKPTP | 1096 | Q6ZRS2 | |
| TPTLSLKPTPPAPVR | 1101 | Q6ZRS2 | |
| PSPTPLPTLPKELTS | 1086 | A1L4H1 | |
| ETIKSLTALPTPPPP | 271 | O00623 | |
| DLTRTPPPPSSTFPK | 546 | Q86SQ0 | |
| PSQKSSLPPLLIPPS | 86 | Q9UJM3 | |
| GPALTTPKEPTPTTP | 341 | Q92954 | |
| APLISTPPSRPPQVK | 461 | Q01826 | |
| SCPLPPVTSPLKPNT | 241 | Q8WXE9 | |
| PVTSPLKPNTPPSAS | 246 | Q8WXE9 | |
| KSSPTPNPPIFSLPL | 1121 | Q96JN2 | |
| ISSTTSPKLNPPPSP | 381 | A6NIR3 | |
| SPTTTPPTKPPSFNL | 71 | Q99966 | |
| SVPSAPPPKAQSVSP | 891 | Q96RK0 | |
| PPPSPAKSDTLIVPS | 491 | Q14028 | |
| TPSKVTARPSQPPLP | 876 | Q9ULV3 | |
| CTLPPPFNIIPSPKT | 676 | P48995 | |
| PPSLKTRPPSPTFIT | 2936 | A4UGR9 | |
| PLPKSLAIPSTPPNS | 766 | O60296 | |
| KIPNTVSTPLQAPPP | 1981 | Q86UP3 | |
| LSSAPTKPLLQTPPP | 3101 | Q86UP3 | |
| KIPPPSINFTLPSPV | 1671 | Q8N2C7 | |
| PPSSPLPSKSTSAPQ | 451 | Q14157 | |
| PSTPSPPKPTGIFQT | 591 | O15027 | |
| PTPVPKSIPISETPN | 346 | A7XYQ1 | |
| PPKPSSPVSSPNQLR | 191 | O95171 | |
| KPPVPSTPRPSASSQ | 291 | O43516 | |
| SLPPPALKTSPIQPI | 671 | Q2M1Z3 | |
| PLNSTPATTTEPPKP | 306 | O43670 | |
| KTPSKPPAQLSPSVP | 256 | P18887 | |
| KSPSSSQPLPQVPAP | 201 | Q15942 | |
| SPVSPSLKGQVPPPS | 326 | O15016 | |
| LPKIPIPSVPTFQPS | 101 | Q7L8A9 | |
| GPTTPIPVKASPSPT | 511 | P11498 | |
| PKTTSPEPQESPTLP | 241 | P53814 | |
| LSPTPSEAPKPASLP | 126 | Q9BU19 | |
| PPQATKTTAPVPEPT | 646 | Q86VM9 | |
| SKPLPGSRSTPSPTP | 476 | Q9NW07 | |
| IPPAVTSPSPKEAPT | 1601 | E9PAV3 | |
| PVPTLPPKQQFLPSS | 1806 | E9PAV3 |